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ABSTRACT OF THE DISSERTATION
Action of SNAIL1 Protein is Critical for Fibrosis
by
Hirak ArupKumar Biswas
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2016
Professor Gregory D. Longmore, Chair
Hypoxic injury to the heart causes cardiac fibrosis leading to cardiac dysfunction and heart
failure. SNAIL1 is a zinc finger transcription factor which has been implicated in fibrosis
following organ injury. To investigate the role of SNAIL1 in cardiac fibrosis, we used an
endogenous SNAIL1 bioluminescence reporter mice, and SNAIL1 knockout mouse models.
Here we report that SNAIL1 is expressed in the infarcted myocardium, especially in the
myofibroblasts. Utilizing cardiac fibroblasts in-vitro we demonstrate that pro-fibrotic factors and
collagen increases SNAIL1 in cardiac fibroblasts. By knocking out SNAIL1 in cardiac
fibroblasts in-vitro, we demonstrate that SNAIL1 is required for adoption of myofibroblast fate,
collagen 1 expression and fibrotic genes expression. Taken together the data suggests that
SNAIL1 expression is induced in the cardiac fibroblasts after injury which causes adoption of a
myofibroblast phenotype and a fibrotic scar formation. The collagen deposition in the scar can
maintain the elevated SNAIL1 expression in the myofibroblasts and help to propagate fibrosis.

[viii]

Chapter 1 - Introduction
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Significance
Cardiovascular diseases including hypertension, myocardial infarction, heart failure and
congenital heart defects affect over 82 million Americans 1. Heart failure is an end stage
condition of almost all cardiovascular diseases and annually about 0.7 million people are
diagnosed with heart failure in America2. Cardiovascular diseases and cancer are the two leading
causes of death in the western world and cardiovascular diseases account for one out of three
deaths in the United States, claiming more lives than cancer, lower respiratory diseases and
accidents, making it the leading causes of death in the Unites States 1. The annual cost of
cardiovascular diseases in the United States in 2015 is estimated to be $565 billion and is
expected to increase by 100% in the next 15 years to about 1.1 trillion in 2030 2. The high
economic burden can be attributed to high disease prevalence, costly therapies and hospital stay.
About 69% of the treatment cost is attributed to hospitalizations and 18% for drugs 3.
Cardiovascular diseases represent a huge economic burden on the healthcare system. Therefore,
a better understanding of the mechanisms of cardiovascular diseases development and
progression will lead to better diagnostics, drugs, reduced hospitalizations and ultimately reduce
morbidity and mortality.

Fibrosis – Wound healing gone awry
Injury and wounding to a healthy organ results in healing or repair of the injury. It is the
body’s natural response to injury with the goal of repairing and restoring the function of the
injured organ. The wound healing process requires an orchestrated interplay between various cell
types like epithelial cells, fibroblasts, and immune cells as well as structural proteins of the
2

extracellular matrix and a multitude of cytokines like Transforming Growth Factor, Platelet
derived growth factor etc4. Wound healing begins immediately after injury and is a dynamic
process that involves many distinct but overlapping phases. Immediately after the injury, a fibrin
clot forms at the wound to prevent blood loss and creates a temporary matrix for the cells
involved in wound healing to anchor and/or pass to the injury site 5. The fibrin clot contains
important signaling molecules like TGF, PDGF etc. which are important for recruiting and
activating cells which lead to wound healing6. After the wound is stabilized, the inflammatory
phase begins. Macrophages, neutrophils and lymphocytes migrate into the injury site 7. The major
function of the neutrophils is to protect against bacterial infection and clear cellular debris.
Tissue macrophages clear the expanded neutrophils and damaged tissue thereby controlling and
limiting the extent of inflammation8,9. The proliferation and migration phase occurs next. This
involves proliferation and activation of fibroblasts, keratinocytes and the induction of
angiogenesis. T-lymphocytes and bone marrow derived cells can also migrate to the wound site.
Following this, the reparative and remodeling phase follows. Granulation tissue is created at the
injured site. To do so fibroblasts present at the wound are activated and become SMA

expressing myofibroblasts. Myofibroblasts generate the extracellular matrix at sites of repair
(i.e., granulation tissue), remodel the ECM, and promote wound contraction, a process in which
the wound edges move towards the center10. Next, re-epithelialization occurs as cells move over
the granulation tissue and close the wound5.
During the wound healing process, the acute inflammation and wound healing
mechanism can become chronic which can lead to excessive accumulation of ECM components
and fibrotic scar formation. Fibrosis occurs when the rate of ECM deposition by the
myofibroblasts exceeds the rate of ECM degradation and turnover. The fibrotic ECM mainly
3

comprises of collagens I and III and is non-contractile. Persistent fibrosis leads to interference of
the normal tissue functions, which over time can lead to organ failure 11.

Cardiac fibrosis
Cardiac injury leads to extensive repair and also structural and functional remodeling.
This can include cardiomyocyte hypertrophy and extracellular matrix deposition, i.e. cardiac
fibrosis12. Cardiac fibrosis results in both systolic and diastolic dysfunction of the heart and also
causes increased arrhythmias due to decreased coupling of fibroblasts and myofibroblasts 13. The
increased arrhythmias are correlated with sudden cardiac death 14. A study found that 3% increase
in fibrosis tissue is associated with 50% increase in adverse cardiac event risks 15.
Myocardial fibrosis is classified into two types; reactive fibrosis and replacement
fibrosis16. Reactive fibrosis is similar to fibrosis occurring in other organs. In the heart, reactive
fibrosis causes extracellular matrix deposition in the perivascular spaces and cardiac intersitium.
Cardiomyocyte hypertrophy occurs in reactive fibrosis but there is no loss of cardiomyocytes.
Pressure overload, renin-angiotensin II-aldosterone signaling, endothelin can cause reactive
fibrosis17. In replacement fibrosis, the extracellular matrix deposition occurs at the site of
cardiomyocyte loss. For example, during myocardial infarction, a blockage in an artery
supplying blood to the heart causes hypoxia in the region supplied by the artery due to loss of
blood flow. This leads to cardiomyocyte death that is replaced by scar tissue comprising mainly
of collagens.
Wound healing following myocardial infarction leads to the three distinct but overlapping
phases of wound healing i.e. inflammatory phase, proliferative phase and maturation phase 18. In
4

the mouse heart, the inflammatory phase occurs between 3-72 hours post injury and is
characterized by an influx of leukocytes. Between 2-7 days, the immune response begins to
subside and fibrous tissue is deposited and neo-vascularization in the scar takes place. From day
7-21 days post infarction, the more matrix is laid down and the fibroblasts begin to clear leaving
behind the fibrotic scar18.
The cardiac fibroblasts are the major player in the cardiac fibrosis process 19. In the
normal, uninjured heart, cardiac fibroblasts have distinct functions like maintaining the
extracellular matrix homeostasis, production of growth factors and cytokines, homeostasis of
cardiac blood vessels and cardio electrophysiology by coupling myocytes and propagating
electrical signals20. In response to hypoxic injury, the cardiac fibroblasts accumulate in the
infarcted myocardium, become activated and adopt a myofibroblast phenotype. The
myofibroblasts are characterized by the expression of alpha smooth muscle actin (SMA) and
thus are contractile cells. The myofibroblasts are activated by pro-fibrotic cytokines in the infarct
area and are responsible for secreting the extracellular matrix and the ECM remodeling enzymes
such as growth factors and proteases. In the heart, the markers for cardiac fibroblasts are the
collagen receptor Discoidin domain receptor 2 (DDR2), fibroblast specific protein 1 (FSP1) and
the intermediate filament vimentin and are distinguished from myofibroblasts by the expression

of SMA and periostin19,20. However, these distinctions may not be accurate as the fibroblasts /
myofibroblasts might not be a static population of cells. Their heterogeneity might be a result of
their different origins and also the surrounding environment.
The origin of myofibroblasts in the infarct zone is an area of active investigation. Since
the cardiac fibroblasts are the major cell type in the heart by numbers and even outnumber
cardiomyocytes and are sensitive to circulating pro-fibrotic factors, thus making them the likely
5

source of the myofibroblasts in the injured sites21,22. However, there are other sources of
myofibroblasts in the infarcted area. It is estimated that ~30% of the myofibroblasts arise from
the endothelial cells by a process called endothelial to mesenchymal transition (EndMT) 23. The
perivascular cells, surrounding blood vessels, have been shown to give rise to collagen producing
myofibroblasts in dermal scarring and kidney fibrosis24,25. However, this has not been
demonstrated in the heart due to lack of a pericyte specific lineage tracing tool in the heart 26.
Bone marrow derived progenitor cells and circulating fibrocytes have been shown to be present
in the infarcted myocardium and can give rise to 25-60% of the fibroblasts 27. However, this
population declines during later scar maturation phases 28,29. Thus it would be fair to assume that
the cardiac fibroblasts in the infarcted myocardium are derived from multiple sources but
whether they are functionally similar, in addition to being phenotypically similar remains to be
seen.
The main structural proteins in the fibrotic scar secreted by the myofibroblasts are
fibrillar collagens i.e. collagens I and III. In the mature scar about 85% of the collagen is
collagen I and about 11% collagen III. Collagen I is associated with thick fibers which are more
tensile and are resistant to stretch and deformation. Collagen III is associated with thin fibers
which confer more resilience. In the infarct zone, collagen III is first synthesized. As the scar
matures, the collagen III is replaced by collagen I, thereby increasing the collagen I/III ratio and
increased resistance to distension with more tensile strength 30. Periostin is another matricellular
protein that is secreted by the cardiac myofibroblasts in the infarct zone. Periostin has been
suggested to regulate collagen fibrillogenesis by allowing collagen cross linking 31,32 and also
serves as a ligand for avb3 and avb5 integrins33.
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In addition to secreting the ECM components, the myofibroblasts actively remodel the
ECM. Myofibroblasts secrete lysyl oxidases, various matrix metalloproteinases (MMPs) and
tissue inhibitor of metalloproteinases (TIMP’s) during cardiac fibrosis 19. In patients with
myocardial infarction MMP2, MMP9, TIMP1, TNF and IL6 were elevated as compared to
healthy controls19. In mice, deletion of MMP2 and MMP9 have a better outcome, measured as
less death due to cardiac (left ventricle) rupture and reduced LV dilation and dysfunction 34,35.

TGF – multipotent pro-fibrotic cytokine
In response to cardiac injury, a variety of cytokines, chemokines and mitogens are

secreted in the infarcted area. These include transforming growth factor , platelet derived
growth factor (PDGF), connective tissue growth factor (CTGF), fibroblast growth factor family
(FGF’s), interleukins 1, 6, 8 and many others. These signaling molecules act through different
receptors and signal transduction pathways, although many of these signaling pathways share
some convergence distally (e.g. activation of MAP kinases) 36. All of these factors act on the
cardiac fibroblasts and can have multiple and overlapping effects, such as activation of fibroblast
migration, proliferation, collagen synthesis, matrix degradation etc. In addition to these secreted
molecules, the physical or mechanical properties of the extracellular matrix can also have profibrotic signals37. Matrix stiffness is associated with wound healing and fibrosis 38. For example,
cardiac fibroblasts secrete collagen III and these fibers might be regulated by mechanical
stretching39. Collagens, periostin, fibronectin and other ECM components can also activate the
cardiac fibroblasts, through the action of the collagen receptor Discoidin domain receptor
(DDR2) or integrin activation and signaling.

7

TGF is a multifunctional cytokine and central mediator in cardiac fibrosis and
remodeling. There is a marked increase in TGF production and activation following myocardial
infarction. The metalloproteinases MMP2 and MMP9, which are secreted by cardiac fibroblasts,
can convert latent TGF present in the myocardium to active TGF in the ECM40,41, 42.
Additionally, Thrombospondin I and avb6 integrin signaling can activate TGF. Active
TGF binds to its receptors which are type I and type II transmembrane serine-threonine kinase
receptors. Binding of TGF activates receptors through transphosphorylation of the receptors.
The active receptors now phosphorylate various downstream signaling effector molecules like
SMAD2/3 (activating SMAD) or SMAD6/7 (inhibitory SMAD’s) and thus affect a variety of
cellular signaling cascades depending on the context 42.
TGF induction has shown to enhance ECM deposition by mesenchymal cells by
expressing ECM genes and suppressing genes involved in ECM degradation (for example:
MMP’s)45,46. The importance of TGF in wound healing and fibrosis is demonstrated by the
severely impaired wound healing and collagen deposition in mice deficient in TGF147, 48. The
induction of collagen by TGF is an immediate-early effect, under the control of SMAD3
transcription factors46. Fibroblasts deficient in Smad3 gene fail to upregulate type I collagen and
CTGF in response to TGF. Interestingly, fibronectin gene induction is independent of SMAD
but requires JNK MAP kinase cascade49. SMADs 3 and 4 have been shown to bind to the Col1a2
promoter at the SMAD recognition motif CAGACA directly50. Col1a1 promoter lacks SMAD
recognition element, but SMAD2 forms a complex with Sp1 and binds to the Col1a1 promoter at
the -162 to -142 regions and activates Col1a1 gene transcription 51,52. The induction of collagen I
in mesangial cells with TGF treatment required RAS/MEK/ERK MAP kinase cascade but not
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p38 MAP kinase cascade. However, in dermal fibroblasts, p38 MAP kinase cascade, but not
RAS/MEK/ERK MAP kinase cascade is required to upregulate collagen I gene transcription.
CTGF gene induction by TGF stimulation requires the RAS/MEK/ERK MAP kinase cascade.
In addition to induction of pro-fibrotic gene expression, TGF signaling has effects on
cardiac fibrosis. TGF can be chemotactic for neutrophils and monocytes contributing to the
migration of these cells into the infarcted region. Depending on the cytokine milieu, TGF can
prevent migration of neutrophils across the endothelial cells. These different roles for TGF
could explain the initial migration of neutrophils and leukocytes in the infarct area, which then
subsides as the scar matures. TGF also can stimulate fibroblasts, including cardiac fibroblasts,

into SMA expressing myofibroblasts. Signaling through the Rho > Rock > MRTF A/B > SRF
pathway by TGF stimulation is important for expression of SMA in the myofibroblasts. In

colonic myofibroblasts, it has been shown that Rho kinase is required for TGF induced SMA
and collagen expression53–55.
microRNA 29 family has been shown to affect fibrosis in multiple organs, including
heart, kidney and liver. TGF has been shown to suppress miRNA 29 during cardiac, renal
fibrosis and hepatic fibrosis and this suppression is mediated by SMAD3 56,57. miRNA 29 has
multiple functions during fibrosis. In the heart fibroblasts, renal tubular epithelial cells and
hepatocytes, miR29 has been shown to downregulate expression of fibrosis genes like collagens I
and III58. In addition, TGF stimulation of myoblasts represses miR29 through the binding of
SMAD3/YinYang1/EzH2 complex at the SBE/CAAT domain in the promoter if mir29 59.
Interestingly, there is a Ebox sequence, just upstream of the SBE/CAAT domain 59. Inhibition of
miR-29 expression by TGF-beta-Smad3 signaling could happen via SNAIL1 binding to this
9

Ebox sequence and its interaction with the SMAD3 complex at the SBE/CAAT domain. Thus
repression of miR29 after stimulation of TGF results in expression of collagen genes in
response to TGF signaling.

SNAIL1 and its role in fibrosis
Epithelial to Mesenchymal transition (EMT) is a morphogenetic cell transformation
process where epithelial cells lose their polarity, epithelial gene expression and start expressing
mesenchymal genes and become motile60. Such EMT processes is necessary for normal
development i.e. gastrulation and also in pathologies i.e. cancer cell motility61. EMT can be
triggered by a variety of signaling molecules and pathways, including TGF, all of which
converge on a set of transcription factors called EMT inducers. The transcription factor SNAIL1
has been shown to be the master regulator of EMT gene expression 62. SNAIL1 induced EMT is
critical for embryogenesis as SNAIL1 knockout mice fail to undergo gastrulation. During the
cardiac development TGF induced EMT has been shown to be important for invasion into the
cardiac jelly via SNAIL1 repression of VE-Cadherin63–65
Snail1 is a member of the Snail superfamily of zinc finger transcription repressors. The
Snail superfamily is highly conserved from insects to mammals and plays a critical role in
morphogenesis, especially mesoderm formation during gastrulation. The C-terminal region of the
Snail family transcription factors contain four to six highly conserved zinc finger domains of
C2H2 type. The zinc finger domains recognize and bind E-box sequences (CAGGTG). SNAIL1
repression activity is due to the SNAG domain in the amino terminal region via interaction of
SNAIL1 with the co-repressor CtBP, polycomb complex 2, SIN3A/HDAC complex and Ajuba 66.
10

During the induction of EMT, SNAIL1 represses epithelial genes such as E-Cadherin,
desmoplakin, cytokeratin 18, in addition to directly or indirectly upregulating mesenchymal
genes such as vimentin and fibronectin. SNAIL1 has also been shown to actively modulate gene
transcription by modulating heterochromatin regulation by interaction with LoxL2. Although,
SNAIL1 is classically studied as a transcriptional repressor, certain modifications, such as
acetylation of SNAIL1, causes it to function as a transcriptional activator 67. Acetylated SNAIL1
induced cytokine gene activation influences macrophage recruitment by tumor cells 67.
SNAIL1 is highly regulated as aberrant activation or upregulation of SNAIL1 might have
unwanted consequences. For example, SNAIL1 has been observed in the nuclei of cells
transitional cells, which are myofibroblasts derived from epithelial origin, in the fistulae from
Crohns disease patients, suggesting a role for EMT in the etiology of Crohns disease 68. SNAIL1
is regulated at multiple levels including transcription, translation, post-transcriptional
modification and protein stability. Stimulation with TGF can induce SNAIL1 gene transcription
and once SNAIL1 is produced, it represses its own expression by binding to Ebox sequences in
this own promoter. This transient upregulation of SNAIL1 is sufficient for induction of EMT in
MCF10A mammary epithelial cells62. Furthermore, at the transcriptional level, SNAIL1 is
regulated by the action of microRNA’s during the induction of EMT. miRNA-34 and miRNA-30
have been shown to repress SNAIL1 by binding to 3’UTR of SNAIL1 69,70. Once Snail1 mRNA
has been transcribed, SNAIL1 is phosphorylated at its Nuclear Localization Signal (NLS) (amino
acids 132-143), is imported to the nucleus by the binding of CRM1 transporter 71. SNAIL1 is a
highly unstable protein with a half-life of 25 minutes. The GSK3 can phosphorylate SNAIL1 at
nuclear export site which triggers its translocation from nucleus to cytoplasm, followed by
another phosphorylation by GSK3 in the nucleus. This dual phosphorylation targets SNAIL1
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for degradation by the ubiquitin-proteasome pathway72,73. Other E3 ligases like FBXL14 can
target SNAIL1 for degradation and in response to hypoxia FBXL14 is down-regulated which
ultimately increases SNAIL1 levels74. Another E3 ligase FBXL5 can polyubiquitinate SNAIL1
affecting its stability and DNA binding capacity75.
In addition to being involved in EMT events during normal development, SNAIL1 is also
implicated in wound healing, pathological conditions such as fibrosis and cancer. SNAIL1
upregulation in mesenchymal cells (fibroblasts) has been shown to induce cell invasion and
migration and disrupting SNAIL1 prevents fibroblasts from migrating into a wound site 76.
SNAIL1 has been shown to be upregulated during fibrosis following organ injury. Using
knockout mouse models, SNAIL1 has been shown to be important in hepatocytes for liver
fibrosis following injury77. In a kidney injury model, SNAIL1 induced endothelial to
mesenchymal transition (EndMT) was shown to contribute to fibrosis 78,79. Recently, SNAIL1
expression was detected in cardiac fibroblasts and cardiac endothelial cells following ischemia
reperfusion injury to the heart80. SNAIL1 in endothelial cells was necessary for secretion of
connective tissue growth factor that caused neighboring fibroblasts to adopt a myofibroblast
phenotype81. In the pancreas, SNAIL1 co-operates with KrasG12D to promote fibrosis via
activation of stellate cells and increased phosphorylation of Smad2 and TGF282.
Expression of SNAIL1 has been linked to a variety of cancers including breast cancer,
bladder cancer, cervical cancer, colorectal cancer, pancreatic cancer etc. SNAIL1 expression in
epithelial tumors induces EMT, invasion, migration and has been associated with cancer
stemness and resistance to chemotherapy83,84. High SNAIL1 expression in tumors often corelates with poor differentiation, increased migration, invasion and metastasis and prognosis 84.
The cancer microenvironment is highly fibrotic and stiff due to excess ECM deposition and as
12

such might be tumor promoting via mechanical signals 37,85–87. Increasing evidence suggests that
SNAIL1 expression in the cancer micro-environment can support metastasis. SNAIL1
expression in cancer associated fibroblasts (CAF’s) can increase extracellular matrix stiffness
and anisotropic fiber alignment which allows cancer cells to migrate and invade 88. SNAIL1
expression has been observed in tumor stroma in multiple human cancers. For example, in
tumors from colorectal cancer patients, SNAIL1 expression co-related with fibroblast markers
like aSMA and fibroblast activated protein (FAP)89. SNAIL1 expression in colon cancer CAF’s
can be used as a prognostic marker90.

Fibrosis therapies
Fibrosis following injury can occur in any organs and thus collectively, fibrosis is one of
the largest group of diseases 17. Once established, fibrosis is hard to treat as removing the
deposited scar tissue is not trivial. The main approach to treat fibrosis has been to suppress the
fibrotic reaction, thus to prevent further ECM deposition. In the case of cardiac fibrosis
following a trans-mural myocardial injury (infarction), the formation of a scar is necessary to
close the wound created by dying cardiomyocytes. A failure of scar formation in the infarct area
might lead to cardiac rupture. However, since the scar matures and becomes fibrotic, the
therapies aimed to prevent cardiac fibrosis need to be directed toward making a ‘better scar’, i.e.
have enough scar formation to prevent rupture at the infarcted area but prevent the excessive
ECM deposition and preserve heart function.
Although fibrosis is a widespread disease, there aren't many approved therapies to
prevent or treat fibrosis. There have been several approaches under investigation to prevent
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excessive collagen deposition in fibrosis. As such, the signaling molecules and pathways
involved in fibrosis like collagen synthesis, deposition and cross linking pathways, chemokines
that recruit immune cells, conversion and recruitment of myofibroblasts, represent attractive
targets to prevent fibrosis. Small molecule drugs like Pirfenidone which targets signaling
molecules involved in fibrosis (TGF, TNF and IL10) and the multi-tyrosine kinase inhibitors
like Nintedanib have been approved to treat idiopathic pulmonary fibrosis (IPF) and
investigation is underway for treatment of these drugs for other fibrosis diseases. Some other
examples of small molecule drugs that have been tested as anti-fibrotic agents are Losartan (AT1
receptor antagonist), Atrasentan (ETA receptor antagonist) and Rosiglitazone (oral). Several of
these small molecule compounds are in advanced stages of clinical trials (phase III).
Interestingly, a majority of the molecule agents have been tested for pulmonary, skin, liver and
kidney fibrosis. The only two small molecule agents tested in cardiac fibrosis in pre-clinical
models are Distertide (P144) - a TGF inhibiting peptide and MMI-0100 - MK2 peptide
inhibitor91.
In addition to small molecule inhibition of fibrosis, there have been several biological
inhibitors of fibrosis tested. For example, GC1008, a humanized antibody against TGF1, 2 and
3, and LY2382770, a humanized antibody against TGF1 are in clinical trials for treatment of
fibrosis diseases. STX-100 an av6 integrin blocking antibody is being tested for idiopathic

pulmonary fibrosis and GS-6624, a non-competitive allosteric antibody to LoxL2 is also being
tested as an anti-fibrotic agent. Several microRNA’s that are involved in the fibrogenic pathway
are under investigation as potential therapeutics by some companies like miRagen and Regulus
Therapeutics92. Recently, gene therapy approaches have been investigated to repair mutations in
CFTR genes as therapy for cystic fibrosis. Another novel approach to treat cardiac fibrosis is to
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genetically convert cardiac fibroblasts to cardiomyocytes. Using retroviral vectors expressing a
defined set of transcription factors and genetic lineage tracing methods, cardiac fibroblasts were
shown to be able to re-program into cardiomyocytes after myocardial infarction in mice 93.
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Chapter 2: Role of SNAIL1 in cardiac fibrosis
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Introduction
Hypoxic (ischemic) injury to cells and organs such as occurs to the heart during
myocardial infarction due to artery occlusion result in a wound healing process 11. Hypoxia
causes death of cardiac cells and as a result the release of inflammatory mediators and
subsequent inflammation in the injured region. This inflammatory response sets up a wound
healing cascade which ultimately deposits fibrous scar tissue in the infarcted region. The scar
consists of deposited extracellular matrix (ECM), and is the attempt to prevent rupture of the
dead cardiac tissue11. However, when the scarring reaction is persistent this can lead to excess
deposition of extracellular matrix (ECM) and cardiac fibrosis, which leads to stiffening of the
heart, reduced cardiac output (ventricle dysfunction), and heart failure 11. Therefore,
understanding of the mechanisms for and regulation of cardiac fibrosis following injury could
result in development of anti-fibrotic therapies to improve quality of life after myocardial
infarction.
In the heart fibroblasts are the major cell type responsible for generating the fibrotic
reaction after ischemic injury26. In term of numbers, cardiac fibroblasts make up the majority of
the cells in the heart, even outnumbering the cardiomyocytes 20. In response to ischemic injury,
the number of cardiac fibroblasts at the injury site increase and become activated to
myofibroblasts26. The increased number of myofibroblasts in the scar area are derived from
various sources that include: proliferation of resident cardiac fibroblasts, Endothelial to
Mesenchymal Transition of endothelial cells, circulating fibrocytes, pericytes and inflammatory
cells and bone marrow derived mesenchymal progenitor cells 26. These activated fibroblasts, or
myofibroblasts, express the markers alpha smooth muscle actin (SMA) and periostin and
secrete pro-fibrotic and pro-inflammatory cytokines as well as ECM proteins and ECM
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modifying enzymes in the scar area. The deposited ECM is mainly comprised of fibrillar
collagens (collagens I and III). Periostin, secreted by myofibroblasts, regulates the alignment of
the collagen I fibrils32 while secreted enzymes that cross-link collagen fibers (e.g., lysyl
oxidases) can increase tissue stiffness94.
A number of transcriptional regulators have been implicated as contributing to fibroblast
to myofibroblast phenotypic switch. Their expression is activated by inflammatory cytokines
released after hypoxic injury. For example, the serum response factors (SRF), Myocardin
Related Transcription Factor A/B (MRTFA/B)95. Another critical mesenchymal cell
transcriptional regulator is SNAIL1, and SNAIL1 has been shown to be important for organ
fibrosis that develops following liver77 and kidney injury78, as well as the fibrosis associated with
some cancers37,88. Recent studies have suggested that SNAIL1 expression in the heart is
activated following ischemia. Increased SNAIL1 levels in endothelial cells following ischemia
reperfusion cardiac injury causes secretion of connective tissue growth factor (CTGF) by
endothelial cells, which in turn activates neighboring cardiac fibroblasts to form myofibroblasts
81

. Whether SNAIL1 is actually necessary for cardiac fibrosis following ischemic injury, and if

so in what cells in the heart and how, is unknown.
SNAIL1 is a critical mesenchymal cell fate regulator and a zinc finger transcriptional
repressor, although a recent study suggests that under certain conditions and in the presence of
specific co-factors it can act as a transcriptional activator67. SNAIL1 protein level and function is
regulated at the transcriptional and post-transcriptional levels by various chemical and
mechanical extracellular stimuli that can be present in the hypoxia-injured heart. These include:
TGF, PDGF, hypoxia and increased ECM stiffness. Using a SNAIL1 reporter mouse and
immunohistochemical analyses we find that SNAIL1 levels are increased in heart fibroblasts
18

following hypoxic injury. Through genetic manipulation of SNAIL1 expression in primary heart
fibroblast cells ex vivo we find that SNAIL1 is critical for the formation and function of
myofibroblasts and their fibrotic response following TGF stimulation.
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Results
SNAIL1 expression in the heart increases post myocardial infarction
To determine whether SNAIL1 expression in the heart was induced in response to
ischemic cardiac injury, we made use of a SNAIL1-Click Beetle Red (CBR) fusion
bioluminescence reporter mouse (Figure 2.1A)62. In this mouse the CBR bioluminescent enzyme
was inserted into the SNAIL1 gene, in frame, downstream of the third (terminal) exon of
SNAIL1 so as to generate a SNAIL1-CBR fusion allele. Through this design, SNAIL1-CBR
expression is under regulation of the endogenous SNAIL1 promoter.
Heterozygote SNAIL1-CBR/+ mice did not express SNAIL1-CBR in the uninjured
normal heart (Figure 3.3C). To induce hypoxic cardiac injury, SNAIL1-CBR/+ mice were
subjected to Left Anterior Descending (LAD) Artery ligation. Hearts were harvested and
analyzed 7-days post-surgery. In sham treated mice there was minimal SNAIL1-CBR
bioluminescence detected, but in SNAIL1-CBR/+ mice subjected to LAD ligation these was a
10-fold increase in bioluminescence signal (Figure 2.1C, quantified in 2.1D). SNAIL1-CBR
signal was restricted to the ventricular infarct area (Figure 2.1C). SNAIL1 mRNA levels also
increased in the hearts of mice exposed to hypoxic injury, as determined by Q-PCR of tissue
from the ventricular region of infarcted and sham surgery control hearts (Figure 2.1E). Like the
LAD ligated hearts, SNAIL1-CBR signal increased in hearts injured by ischemia reperfusion
surgery, albeit to a lesser level than LAD surgery heart (Figure 2.2A, quantified in Figure 2.2B)
Fibrogenic gene expression (e.g., collagen I and III, CTGF, IL6, TGF and periostin) increased
in the infarct region of LAD ligated hearts (Figure 2.3A) and IR hearts (Figure 2.3B). The
increased SNAIL1-CBR levels were co-related with increased fibrosis as determined by
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Masson’s trichrome staining and decreased ejection fraction of the heart, determined by
echocardiogram (Figure 2.3 C and D).
In sum, following ischemic injury to the heart SNAIL1 mRNA and protein level
increased in the infarct zone.

Myofibroblasts within the infarct zone express SNAIL1
To identify which cells within the infarct zone expressed SNAIL1, we performed coimmunostaining with different cardiac cell type markers and CD45 (infiltrating leukocytes).
SNAIL1 staining was observed only in infarct zone and not the non-injured, remote zone (Figure
2.5 and 2.6). A significant number of SMA (40%) and periostin (31%) positive myofibroblasts
in the infract zone expressed SNAIL1. A small proportion (~10%) of CD45 positive leukocytes
expressed SNAIL1 (Table 2.1). SNAIL1 expression was not detected in -actinin positive

cardiomyocytes within the infarct zone (Figure 2.5E). Contrary to previous reports 81 we did not
observe SNAIL1 staining in CD31 positive cells within the infarct zone. In sum, these results
indicated that following cardiac ischemic injury the increase in SNAIL1 expression within the
infarct zone was predominantly in activated myofibroblasts.

Pro-fibrotic factors increase SNAIL1 expression in cardiac fibroblasts.
When activated, such as following exposure to hypoxia, cardiac myofibroblasts secrete a
variety of pro-fibrotic factors. To determine whether these pro-fibrotic factors influenced
SNAIL1 expression in cardiac fibroblasts/myofibroblasts, we isolated primary cardiac fibroblasts
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from normal, uninfarcted SNAIL1-CBR/+ mice. Their fibroblastic origin was confirmed by
intermediate filament vimentin staining and Discoidin Domain Receptor 2 (DDR2) western blot
(Figure 2.7A and B). Since SNAIL1 expression is induced simply by exposing fibroblasts to
serum76, cardiac fibroblasts were first starved of serum for 4 hours prior to treating with profibrotic factors. TGF, PDGF, CoCl2 (hypoxia mimetic agent) and angiotensin II all increased
SNAIL1-CBR bioluminescence signal (i.e., increased SNAIL1 protein level) (Figure 2.8A - D).
In combination these factors did not exhibit any additive effect on SNAIL1-CBR
bioluminescence value. (Figure 2.8E). The effect of most of these pro-fibrogenic factors upon
SNAIL1 level was at the protein level, as only TGF treatment increased SNAIL1 mRNA
(Figure 2.8F).

SNAIL1 knockout cell line creation and verification
To study the function of SNAIL1 in cardiac fibroblasts, we created a cell line to easily
delete SNAIL1. To accomplish this, we isolated primary cardiac fibroblast from normal
SNAIL1f/f; ROSA-LSL-tdTomato mice. To delete SNAIL1, the cells were infected with either
Adeno-LacZ (CTL) or Adeno-Cre (+ Cre) virus for 4 hours and then cultured. SNAIL1 deletion
was verified by Q-PCR for SNAIL1 mRNA (Figure 2.9A) and western blot (Figure 2.9B).
Infection with Adeno-Cre virus turned on the Rosa-LSL-tdTomato reporter (Figure 2.9C) and
SNAIL1 immunostaining was performed on the cultured control or Adeno-Cre infected cardiac
fibroblasts, in presence of PDGF (Figure 2.9 D). Furthermore, here was no significant difference
in proliferation or migration during wound healing (scratch assay) of control versus SNAIL1
deleted cells. (Figure 2.10 A and B). After verification, the Snail1f/f; Rosa-LSL-tdTomato
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cardiac fibroblasts were immortalized by allowing them to undergo senescence and repeated
passaging (~15 passages). The cells were sorted by FACS with PDGFR+ antibody and only the
high PDGFRa expressing cells were collected and used for further experiments. We further
determined that SNAIL1 deletion does not affect signaling through the PDGF receptor.

SNAIL1 is important for conversion of cardiac fibroblasts to activated myofibroblasts
The conversion of fibroblasts to myofibroblasts is a crucial step for fibrosis to occur.
SNAIL1 has been suggested to play a role in giving rise to myofibroblasts via EndMT process in
kidney fibrosis78. Whether SNAIL1 can is necessary for conversion of cardiac fibroblasts to
myofibroblasts is unknown. To test this we used the immortalized cardiac fibroblasts isolated
from SNAIL1f/f; ROSA-LSL-tdTomato mice. SNAIL1 was deleted by infection of these cells
with Adeno-Cre expressing viruses. Control cells were infected with Adeno-LacZ viruses. Cells

were then activated by virtue of being plated on plastic (high stiffness). Very few (~10%) SMA
positive (i.e., myofibroblast) cells were detected in SNAIL1 deleted cells (Figure 2.12A,
quantified in 2.12 B). In this experiment, the presence of Tomato positive cells is a surrogate
marker for SNAIL1-deleted cells (i.e., both expression of Tomato and deletion of SNAIL1 are
Cre responsive) and >95% of cells were tomato positive (Figure 2.12A). This was in stark
contrast to the case with control cells. Control cells were tomato negative and SNAIL1 positive,
and ~85% of cells were SMA positive (Figure 2.12A, quantified in 2.12B).

The loss of SMA positive myofibroblasts when SNAIL1 was deleted had functional
consequences. SNAIL1-deleted cardiac fibroblasts (i.e., + Cre) were deficient in contracting
collagen gels (Figure 2.12 C, quantified in 2.12 D). Furthermore, fibrotic gene expression (IL6,
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TGF and CTGF) and collagen remodeling gene expression (periostin and lysyl oxidase L2)
were blunted in SNAIL1-deleted fibroblasts exposed to TGF (Figure 2.13 A-F). Periostin
protein level in SNAIL1-deleted fibroblasts was also decreased (Figure 2.13 G). Collectively,
this suggested that SNAIL1 controls the adoption of the full myofibroblast phenotype by cardiac
fibroblasts, at least following exposure to pro-fibrotic TGFand a stiff environment.

SNAIL1 is required for ECM collagen production and deposition by cardiac
fibroblasts/myofibroblasts
Activated fibroblasts or myofibroblasts are the primary source of matrix secreted in zones
of ischemic injury96. To determine whether SNAIL1 was necessary for matrix deposition by
myofibroblasts, we made use of the immortalized control and SNAIL1 knockout cells indicated
above. When treated with TGF, Collagen I transcript expression increased in control cells, but
not in SNAIL1 deleted cells (Figure 2.14 A). We did not observe any significant change in
collagen 3 level or fibronectin, however (Figure 2.14 B). To assess ECM production by cardiac
fibroblasts, ex vivo, we plated control and SNAIL1-deleted cells in the presence of ascorbic acid
and PDGF for 7 days. Cells were removed and the cell free matrix stained with antibodies
against collagen I or with Sirius red. Matrix produced by SNAIL1 deleted cells exhibited
decreased collagen I staining, as determined by quantitative immunofluorescence (Figure 2.15 A,
quantified in 2.15 B). However, if the cells were not extracted, there was punctate Collagen I
immunofluorescence staining in the SNAIL1 knockout cells. (2.15C). In addition, the SNAIL1
knockout cells had decreased Sirius red staining (Figure 2.15 D), and decreased type I and type
III collagen fibers birefringence of Sirius red sections (Figure 2.16 E, quantified in 2.16 F).
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These results indicated that induced expression of SNAIL1in cardiac myofibroblasts was
necessary for efficient extracellular matrix deposition in response to pro-fibrotic TGF.

Collagen I affects SNAIL1 via DDR2
Excess fibrillar collagen (i.e. collagen I and III) deposition is a hallmark of cardiac
fibrosis. The cardiac (myo)fibroblasts that are responsible for this matrix synthesis express the
fibrillar collagen receptor, Discoidin Domain Receptor 2 (DDR2), a receptor tyrosine kinase. It
has been shown in tumor cells, that DDR2 activation by collagen I can stabilize SNAIL1 via Erk
signaling. Thus we asked whether cardiac fibroblasts can stabilize SNAIL1 in response to
collagen. We plated SNAIL1-CBR/+ primary cardiac fibroblasts isolated from normal
uninfarcted hearts on increasing concentration of collagen I gel for 4 hours and observed
increased SNAIL1-CBR bioluminescence signal with increasing collagen concentration at 4
hours, as compared to baseline signal at time 0 (Figure 2.16 A). Furthermore, we determined that
SNAIL1-CBR bioluminescence signal is elevated over time by plating the SNAIL1-CBR
primary cardiac fibroblasts on plastic or 4mg/mL collagen gel (Figure 2.16 B). To determine
whether the elevated SNAIL1 signal is via DDR2 receptor activation via collagen, we isolated
cardiac fibroblasts from uninfarcted normal DDR2f/f ; Rosa LSL tdTomato mouse. In this mouse,
the exon 8 of DDR2 is flanked by LoxP sites and the tdTomato reporter is used to identify the
cells that express Cre recombinase (surrogate for DDR2 knockout) (Figure 2.17 A). We infected
these cardiac fibroblasts with Adeno LacZ (CTL) or Adeno-Cre (+Cre) to knockout DDR2. We
observed >95% of the cells expressing tdTomato reporter after infecting with Adeno-Cre (Figure
2.17 B). Then the control or DDR2 knockout cells were plated on either plastic (NT) or on
Collagen, treated with TGF for 2 hours and the TGFb was washed out for 6 hours. The DDR2
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knockout cells had decreased SNAIL1 protein levels, even in the normal unstimulated (NT)
conditions. Furthermore, we isolated mRNA from control (AdLacZ) or DDR2 knockout cells
(AdCre) plated on collagen for 4 hours. qPCR analysis showed no significant change in SNAIL1
or Collagen 3a1 mRNA in the control or DDR2 knockout cells. However, the Col1a1 transcript
was reduced in the DDR2 knockout cells.
In sum, these results suggest a role of DDR2 in maintaining SNAIL1 protein levels in
cardiac fibroblasts and the elevated SNAIL1 levels might be responsible for maintaining col1a1
transcript levels.

Pro-fibrotic miR29 family might be regulated by SNAIL1 in response to TGF
TGFb treatment increases levels of Collagen I mRNA via the binding of SMAD2/3 to the
Col1a1 promoter. We show that deletion of SNAIL1 decreases Col1a1 transcript levels, even in
the presence of TGFb stimulation. It is known that microRNA 29 expression is suppressed in the
hearts of infarcted mice and that TGFb exposure can mediate this response in cardiac fibroblasts.
We wanted to determine whether SNAIL1, a transcriptional repressor, can increase collagen I
transcript via mir29 repression. Firstly, to determine whether the collagen (and other fibrosis
related) gene promoters have conserved E-box (CACCTG) binding sites for SNAIL1. Using a
custom bioinformatics software we could not find E-box (i.e. SNAIL1 binding) sequences in the
promoters of fibrillar collagens. Since E-Cadherin is negatively regulated by SNAIL1 binding to
its promoter, we used E-Cadherin promoter to verify the software (Table 2.3). We then looked at
the promoters of mir29 family to determine that all promoters of miR 29 a/b/c have conserved
SNAIL1 binding E-box sequences (Table 2.2). Furthermore, using TargetScan 7.1 mouse, a
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microRNA binding predicting software available online, we determined that the 3’UTR of
collagen I and III mRNA have multiple conserved mir29 binding sites in their 3’UTR (Figure
2.18). Collagen 1a1 mRNA has 3 conserved binding sites and 2 of these sites had strong 8-mer
sequence for miR29 family. Collagen 1a2 has 7-mer binding sequence and collagen 3a1 has one
8mer and one 7mer binding sites for mir29 family (Table 2.4).

\

27

Discussion
The wound healing response following a myocardial infarction (hypoxic injury) is
necessary to form a scar in the infarcted region. Persistent deposition of extracellular matrix,
predominantly collagens I and III, causes fibrosis in the infarct region, leading to decreased
cardiac function. It is well appreciated that the cardiac myofibroblasts are responsible for
collagen deposition in response to pro-fibrotic cytokines including TGF, PDGF and CTGF.
SNAIL1, a zinc finger transcription factor, usually expressed in mesenchymal cells, is necessary
for liver and kidney fibrosis in mice following injury using carbon tetrachloride and urinary
ureter obstruction models respectively. In the heart, SNAIL1 has been shown to be expressed in
cardiac fibroblasts and endothelial cells following Left Anterior Descending Artery Occlusion
(LAD)80 and ischemia-reperfusion (IR)81 injury models, but whether SNAIL1 is necessary for
fibrosis, especially in mesenchymal (non-epithelial) cells in the heart following injury and if so,
the possible mechanism is not well understood.
The infarcted myocardium contains many cell lineages, including cardiac myofibroblasts,
endothelial, circulating fibrocytes, bone marrow derived progenitor cells and moncytes 26. Similar
to previously reported studies, we observe elevated SNAIL1 levels 7 days post hypoxic injury by
Left Anterior Descending Artery Occlusion80 and show that SNAIL1 is expressed predominantly
in myofibroblasts, as identified by SMA and periostin staining, and a small proportion of

CD45+ immune cells. We do not find SNAIL1 expression in endothelial cells as previously
reported, albeit, our analysis is done on L.A.D surgery model rather than a IR surgery model) 81.
It is likely that SNAIL1 is expressed in endothelial cells during early stages of wound healing,
which might enable the endothelial cells to undergo endothelial to mesenchymal transition after
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cardiac injury23 and contribute to increased number of myofibroblasts in the infarct area. The
increase in SNAIL1 level correlates with increased SNAIL1 mRNA, collagen deposition in the
infarct area and increased levels of pro-fibrotic cytokines. Interestingly, these pro-fibrotic
cytokines can elevate SNAIL1 levels in cultured primary cardiac fibroblasts isolated from
normal, uninjured hearts. Cardiac fibroblasts/myofibroblasts in the infarcted region express profibrotic cytokines like TGF, CTGF and IL6 but SNAIL1-deleted cardiac fibroblasts do not
increase pro-fibrotic cytokine gene expression in response to TGF and mechanical stress
(culturing on high tension plastic tissue culture plates). This suggests that the presence of
SNAIL1 in cardiac fibroblasts/myofibroblasts in the infarct region is responsible for increased
the pro-fibrotic genes expression.
Collagens I and III are the primary collagens secreted by the cardiac
fibroblasts/myofibroblasts in the infarcted myocardium in response to pro-fibrotic factors.
SNAIL1-deleted cardiac fibroblasts have reduced collagen I mRNA expression and collagen
deposition in response to TGF. Collagen III expression in response to TGF was unaffected by
the absence of SNAIL1. This may reflect distinct regulation of Collagen I and III gene
expression in cardiac fibroblasts, since collagen III but not collagen I in cardia fibroblasts is
regulated by mechanical stretch signals39. Additionally, SNAIL1 is necessary for extracellular
collagen modifying and crosslinking genes expression, i.e. LoxL2 and periostin. This data
suggests that SNAIL1 is important for collagen deposition and remodeling. Since increased
collagen I deposition increases SNAIL1 levels in cardiac fibroblasts this suggests a feed forward
loop whereby SNAIL1 causes increased collagen deposition, which in turn maintains elevated
SNAIL1 in the cardiac fibroblasts, possibly through the collagen receptor DDR2 87 or mechanical
signals through Integrin activation37
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The cardiac fibroblasts adopt a myofibroblast fate during fibrosis and increase in number in the
infarcted region. SNAIL1 expression is responsible for cell fate changes, for example, during
Epithelial to Mesenchymal transition62 and during embryonic stem cell differentiation97. Whether
SNAIL1 is responsible for the transformation of cardiac fibroblast to myofibroblasts is unknown.
We show that by knocking out SNAIL1, the cardiac fibroblasts do not express the myofibroblast
marker SMA. It is likely that through activation of Rho kinase, the myocardin related

transcription factor (MRTF), which can mediate TGF induced EMT98 and also SMA
expression99, might be either interacting / affecting the activity of SNAIL1 and vice versa.
TGF treatment of cardiac fibroblasts upregulates multiple genes including ECM genes
(collagens), ECM modifiers (periostin, LoxL2) and other profibrotic cytokines (IL6, CTGF).
SNAIL1 gene transcription and protein levels are also increased following TGFyet SNAIL1 is
a transcriptional repressor. So how does SNAIL1 deletion, abrogate the elevation of the above
mentioned TGF, target genes? One possibility is that include that SNAIL1 is acetylated in
cardiac fibroblasts under these conditions and as such now functions as a transcriptional
(co)activator67. Alternatively, TGF could repress microRNA 29 via SNAIL1 action, which then
releases miR29’s inhibition of collagen I and III expression 56. SNAIL1 repression occurs by
binding to E-box sequences in the promoter and indeed, the miR29b promoter has 2 conserved
E-box sequences.
In sum, our data suggest that cardiac fibroblasts in the infarcted myocardium express
SNAIL1 and adopt a myofibroblast phenotype. SNAIL1 contributes to fibrosis by allowing
expression of pro-fibrotic cytokines and deposition and remodeling of the collagen matrix
causing a scar. The pro-fibrotic cytokines and collagen I in turn maintain SNAIL1 levels in the
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myofibroblasts in a feed-forward loop to sustain the fibrotic state. SNAIL1 suppresses
expression of mir29 family which relieves the suppression of fibrosis genes by mir29.
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Figure 2.1:
SNAIL1-CBR signal after myocardial infarction by Left Anterior Descending Artery Occlusion:
(A) Schematic of SNAIL1-CBR bioluminescence mouse.
(B) Timeline and endpoint of experiment.
(C) Representative ex-vivo imaging of hearts of sham or LAD surgery SNAIL1-CBR/+ mouse.
(D) Bioluminescence fold change of ex-vivo hearts from sham (n=3) and LAD (n=4). Sham
bioluminescence values were arbitrarily set to 1.

(E) QPCR for Snail1 transcript from isolated ventricles of sham and LAD infarcted mice. All
values were normalized to GAPDH and fold change was compared to Sham which was
arbitrarily set to 1.
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Figure 2.2:
SNAIL1-CBR signal after myocardial infarction by ischemia reperfusion.
(A) Representative ex-vivo imaging of hearts of sham or I/R surgery SNAIL1-CBR/+ mouse.
(B) Bioluminescence fold change of ex-vivo hearts from sham (n=3) and LAD (n=4). Sham
bioluminescence values were arbitrarily set to 1.

(C) QPCR for Snail1 transcript from isolated ventricles of sham and I/R infarcted mice. All values

were normalized to GAPDH and fold change was compared to Sham which was arbitrarily set to
1.
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Figure 2.3:
Fibrosis gene expression after cardiac injury
(A) QPCR for fibrosis genes from mRNA isolated from ventricles of sham or infarcted hearts by
Left Anterior Descending Artery (LAD) occlusion.

(B) QPCR for fibrosis genes from mRNA isolated from ventricles of sham or infarcted hearts

ischemia reperfusion (IR) surgery. All values done in triplicates. Representative of 2 mice in each
experiment.

(C) Ejection fraction of the mice undergoing sham (n=5), LAD (n=6) or I/R (n=4) surgery 7 days
after surgery. Ejection fraction was determined by echocardiogram.

(D) Trichrome staining for Collagen in sham, LAD and I/R fixed heart sections 7 days after
surgery.
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Figure 2.4:
SNAIL1-CBR signal in Angiotensin II induced fibrosis model
(A) Timeline of experiment. Pumps with saline (control) or Angiotensin II (experimental) were
implanted in the back of the mice for 14 days.

(B) Representative ex-vivo bioluminescence imaging of hearts from saline and Angiotensin II
treated mice at 14 days.

(C) Quantification of bioluminescence units from B. There were 4 mice in saline and 3 in
Angiotensin II treat groups respectively.

(D) Representative images of trichrome staining for collagen in saline and Angiotensin II treated
mice.
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Figure 2.5:
Immunofluorescence staining of SNAIL1 and cardiac cell type markers in the ventricular
infarct zone of LAD surgery mice.
Cardiac cell type markers used:
(A) SMA (alpha smooth muscle actin) – myofibroblast marker
(B) Periostin – myofibroblast marker,
(C) CD31 – endothelial cell marker,
(D) CD45 – leukocyte cell marker,
(E) -actinin – cardiomyocyte marker.
Scale bars: 50 microns
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Figure 2.6:
Immunofluorescence staining of SNAIL1 and cardiac cell type markers in the remote (noninfarct zone) of LAD surgery mice.
Cardiac cell type markers used:
(A) SMA (alpha smooth muscle actin) – myofibroblast marker
(B) Periostin – myofibroblast marker,
(C) CD31 – endothelial cell marker,
(D) CD45 – leukocyte cell marker,
(E) -actinin – cardiomyocyte marker.
Scale bars: 50 microns
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Figure 2.7
Verification of cardiac fibroblasts isolated from uninjured SNAIL1-CBR hearts:
(A) Vimentin staining of SNAIL1-CBR primary cardiac fibroblasts
(B) Western blot showing DDR2 expression in SNAIL1-CBR cardiac fibroblasts and
cardiomyocytes
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Figure 2.8:
Pro-fibrotic factors increase SNAIL1-CBR level in primary cardiac fibroblasts
Primary fibroblasts were isolated from the hearts of un-infarcted, normal SNAIL1-CBR mice.
Bioluminescence signal after treatment with (A) TGFb (2 ng/uL), (B) PDGF (10 ng/uL), (C)
Hypoxia (400 uM CoCl2) and (D) and Angiotensin II (1 uM) Representative data from one of 4
experiments.
(E) Additive effect of pro-fibrotic factors on SNAIL1-CBR bioluminescence signal.
Representative data of 4 independent experiments.
(F) SNAIL1 mRNA fold change in primary cardiac fibroblasts 4 hours post stimulation with
indicated factors. All values were normalized to GAPDH and compared to non-treated cells as
control. Representative example from 3 experiments.
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Figure 2.9:
Verification of SNAL1 deletion in Snail1 f/f cardiac fibroblasts.
(A) qPCR for SNAIL1 mRNA level in SNAIL1f/f; ROSA-LSL-tdTomato cardiac fibroblasts,
treated with Adeno-LacZ (CTL) or Adeno-Cre (+ Cre), with and without TGF stimulation.
(B) Western blotting for SNAIL1 in SNAIL1f/f; ROSA-LSL-tdTomato cardiac fibroblasts,
treated with Adeno-LacZ (CTL) or Adeno-Cre (+ Cre), with and without TGFstimulation
(C) tdTomato expression in Snail1f/f; Rosa LSL tdTomato cardiac fibroblasts after Adeno LacZ
(CTL) or Adeno-Cre (+Cre) infection
(D) Immunofluorescence staining for SNAIL1 infected with Adeno-LacZ (CTL) or Adeno-Cre
(+ Cre), with PDGF (10ng/mL)stimulation.
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Figure 2.10:
Effect of SNAIL1 on proliferation and migration during wound healing
(A) Growth curve of control and Snail1 knockout (+Cre) cells.
(B) Scratch assay of control and SNAIL1 knockout cells (+Cre) with and without TGF
stimulation.
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Figure 2.11.
Characterization of immortalized Snail1 f/f; Rosa LSL tdTomato cardiac fibroblasts.
(A) Live cell fluorescence activated cell sorting (FACS) of immortalized cardiac fibroblasts
(B) Analysis of signaling pathways after PDGF stimulation of PDGFR+ fibroblasts infected
with Adeno LacZ or Adeno Cre virus

54

55

Figure 2.12
SNAIL1 effect on aSMA expression in cardiac fibroblasts.
(A) SMA immunofluorescence of control (CTL) and SNAIL1-deleted (+ Cre) cardiac
fibroblasts.
(B) Quantification of results in (A). 30 fields were counted in each group. Shown is a
representative result of one of 3 independent experiments.
(C) Gel contraction assay of control (CTL) and SNAIL1-deleted (+ Cre) cardiac fibroblasts.
(D) Quantification of (C). Shown is pooled data from 2 independent experiments, done in
triplicates.
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Figure 2.13
Snail1 deletion effect pro-fibrotic cytokines and collagen remodeling proteins.
Relative fibrogenic gene mRNA expression after SNAIL1 deletion and TGF stimulation:
(A) IL6, (B) TGF (C) CTGF
(D), LoxL2, (E) LoxL3 (F) LoxL1
Representative example of 3 separate experiments.
(G-H) Periostin mRNA levels after 2hours and 3 days of TGF stimulation.
(I) Western blot analysis with periostin antibody of extracts from control (CTL) and SNAIL1deleted cardiac fibroblasts. Representative example of one of two separate experiments.
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Figure 2.14:
Effect of Snail1 knockout on extracellular matrix gene expression in cardiac fibroblasts:
mRNA levels of the following ECM and ECM modifying genes with and without TGFb
stimulation (2ng/mL) for 2 hours of control (CTL) and SNAIL1 knockout cells (+Cre)
(A) Col11
(B) Col31
(C) Fibronectin
(D) MMP2
(E) MMP9
(F) MMP1.
Shown is a representative result of one of 4 independent experiments.
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Figure 2.15
Effect of Snail1 deletion of collagen deposition by cardiac fibroblasts
(A) Collagen 1 immunofluorescence of cell free matrix deposited by control (CTL) and
SNAIL1-deleted (+ Cre) cardiac fibroblasts. (n = 2).
(B) Quantification of results in (A).
(C) Collagen 1 immunofluorescence of matrix deposited by control (CTL) and SNAIL1-deleted
(+ Cre) cardiac fibroblasts. (n = 2). Cells were not extracted for this staining experiment.
(D) Detection of Collagen 1 by Sirius Red Staining of cell free matrix deposited by control
(CTL) and SNAIL1-deleted (+ Cre) cardiac fibroblasts. (n = 4).
(E) Birefringence imaging of Sirius red stained matrix produced by control (CTL) or SNAILdeleted (+ Cre) cardiac fibroblasts.
(F) Quantification of Birefringence imaging (n = 4, 20 images counted for each experiment).
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Figure 2.16
Effect of collagen on Snail1 stability:
(A) Relative fold change in SNAIL1-CBR bioluminescence intensity in cardiac fibroblasts
exposed to increasing collagen I concentration. In each condition values at t=0 were arbitrarily
set to equal 1.
(B) SNAIL1-CBR bioluminescence intensity in cardiac fibroblasts plated on 4mg/mL collagen I
over increasing time. A representative example from 3 experiments is shown.
(C) Effect of cyclohexamide on SNAIL1 bioluminescence of SNAIL1CBR/+ cardiac fibroblasts
plated on 4mg/mL of collagen.
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Figure 2.17
DDR2 knockout effect on SNAIL1 stability in cardiac fibroblasts plated on 3D collagen I
matrix.
(A) Schematic of the conditional DDR2 knockout allele.
(B) tdTomato expression in cardia fibroblasts isolated from DDR2 f/f ; Rosa LSL tdTomato mice
and infected with Adeno-LacZ (Control) and Adeno Cre (DDR2 KO) virus.
(C) Western blot with indicated antibodies of control and DDR2 KO cardiac fibroblasts plated on
4mg/mL collagen I gel. (n=2)
(D) qPCR detection for SNAIL1 and Collagens in control and DDR2 KO cardiac fibroblasts
plated on collagen (n=1)
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Figure 2.18
miR29 binding site analysis – predictive analysis
(A) 3’UTR (untranslated region) of Collagen Ia1 mRNA. Binding site of miR-29 indicated in
boxes.
(B) miR-29 binding site conservation across species on the 3’UTR of col1a1 including mouse
and humans.
(C) 3’UTR (untranslated region) of Collagen 3a1 mRNA. Binding site of miR-29 indicated in
boxes.
Data acquired from TargetScan Mouse v7.1
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Figure 2.19
Possible mechanisms of action of SNAIL1 in cardiac fibroblasts
(A) SNAIL1 expression in cardiac fibroblasts converts it into myofibroblasts which setup the
fibrosis cascade in the heart.
(B) Possible role of miR29 regulation by SNAIL1 in response to TGFb and its implication in
promoting cardiac fibrosis.
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Chapter 3: SNAIL1 reporter and knockout mouse models
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Introduction
SNAIL1 is a zinc finger transcription factor involved in the process of Epithelial to
Mesenchymal transition is highly regulated. The tight regulation of SNAIL1 is necessary as
SNAIL1 had very important functions, including cell fate determination during normal
development. For example, SNAIL1 is expression is necessary for gastrulation during
embryogenesis, differentiation of embryonic stem cells and for normal wound healing. Aberrant
or overexpression of SNAIL1 is implicated in multiple diseases like cancer and fibrosis.
Regulation of SNAIL1 levels occurs both at transcriptional and post translational level.
SNAIL1 protein is unstable with a short half-life of 20 minutes and is constantly targeted for
degradation in the cytoplasm by the GSK3B /Axin / catenin complex. SNAIL1 is also self-

regulated at the gene level where increase in SNAIL1 can bind to E-box sequences in its own
promoter and turn off transcription. Furthermore, SNAIL1 is also regulated at the posttranscriptional level by phosphorylation and acetylation and each of these modifications have
different effect on SNAIL1 activity i.e. SNAIL1 can be a transcriptional co-repressor
(phosphorylation) or co-activator (acetylation). Due to the dynamic and transient nature of
SNAIL1, it is difficult to study endogenous SNAIL1 levels and functions in-vivo. Most of the
experiments done to study SNAIL1 in-vivo have been done using qPCR and
immunohistochemical methods which do not represent a complete picture of SNAIL1 expression
pattern, activity or function.
SNAIL1 is a mesenchymal gene whose transcript is expressed at very low levels in both
epithelial and mesenchymal cell types. In epithelial cells, SNAIL1 expression in response to
EMT inducing signals (like TGFb) causes the epithelial cells to undergo EMT by direct
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repression of epithelial genes like E-Cadherin and upregulation of mesenchymal genes like
vimentin. Induction of EMT reduces cell proliferation rates and increases motility of the cells. In
mesenchymal cells, like fibroblasts, SNAIL1 expression is upregulated during wound healing
process following injury.
Most of the experiments done in mouse models to study the effects of SNAIL1 deletion
were done by global deletion of SNAIL1 or deletion in the epithelial cell compartment. Germline
deletion of SNAIL1 causes a failure of the developing embryos to undergo gastrulation causing
the mouse embryo’s to die at e6.5. Deletion of SNAIL1 in the mammary epithelial cells using a
SNAIL1 floxed mouse crossed to MMTV-Cre (Mouse Mammary Tumor Virus), prevents the
invasion of the mammary ductal epithelial cells into the mammary fat pad. Studies done to
elucidate the role of SNAIL1 in fibrosis in the liver were carried out using Albumin-Cre, which
is expressed in hepatocytes. In the kidney, Ksp1.3-Cre (Cadherin-16) was used to knock out
SNAIL1 and its effect on fibrosis was determined. In both the studies, SNAIL1 deletion was
caused a reduction in fibrosis following carbon tetrachloride and urinary ureter obstruction
injury. In the heart, following cardiac injury, the cardiac (myo)fibroblasts increase in number in
the infarcted area and are responsible for fibrosis by deposition of extracellular matrix. We have
shown that in-vitro, SNAIL1 is necessary for conversion of fibroblasts into cardiac fibroblasts.
However, the function of SNAIL1 in-vivo in these cardiac (myo)fibroblasts haven’t been
determined yet.
In the following study, we attempted to determine the cellular identity if SNAIL1
expression at the organ and cellular level in the hearts using different SNAIL1 reporter mice.
Using a reporter mouse, we determined the expression pattern of different mesenchymal Cre
recombinase’s in the heart. We show that SNAIL1 deletion in the fibroblasts do not have any
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effect on mouse development. Knocking out SNAIL1 in the mesenchymal cells suggests that
SNAIL1 is atleast partially responsible for fibrosis in the infarct zone in the heart.
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Results
SNAIL1-LACZ reporter mouse model.
To determine the cellular identity of SNAIL1 expressing cells in the normal and infarcted
heart, we decided to create a SNAIL1-LacZ reporter mouse. We obtained two SNAIL1-LacZ
reporter Embryonic stem (ES) cells (denoted AE3 and AG11) from the international mouse
consortium (KOMP) repository. The ES cells were in the BL/6 background. The SNAIL1
targeting allele is shown in Figure 3.1A. In these ES cells, one of the two alleles of SNAIL1 is
replaced by knocking in a SNAIL1-LacZ reporter construct. Thus SNAIL1 expressing cells in
this mouse would be identified using beta-galactosidase (X-Gal) staining. The ES cell lines
expressed LacZ gene, determined by PCR (Figure 3.1B). Since SNAIL1 is expressed during ES
cell differentiation, we induced ES cells to differentiate by plating them on tissue culture plated
in absence of LIF (Leukemia Inhibitory Factor). By staining the ES cells undergoing
differentiation with beta-galactosidase we observed LacZ staining in both the ES cell strains.
However, when the ES cells were injected in the blastocyst and implanted in a pseudo-pregnant
mouse, we obtained only 3 chimeric mice from the AG11 ES cell line. Out of these, 2 chimeric
mice died soon after birth and from the remaining chimeric mouse, we did not obtain germline
incorporation of the SNAIL1-LacZ allele. The AE3 ES cells injected mice did not bear any litter.
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SNAIL1-IRES-YFP mouse characterization
SNAIL1-IRES-YFP mice were a kind gift from Dr. Xin Ye and Dr. Robert Weinberg
(Whitehead institute). In this mouse, the third exon of SNAIL1 is fused to an IRES-YFP cassette
(Figure 3.2 A). Thus any cell expressing SNAIL1 will be YFP positive. Since SNAIL1 is not
fused to the YFP reporter, only the cellular identity of SNAIL1 expressing cells can be
determined but YFP expression cannot be used to determine the levels of SNAIL1 or the
subcellular localization. When normal uninfarcted hearts were obtained and stained using YFP
antibody, we saw very few positive cells in the heart (Figure 3.2 B). In contrast, there were a
significant number of YFP expressing cells (Figure 3.2C) When cardiac fibroblasts from the
SNAIL1-IRES-YFP mouse was isolated and cultured in tissue culture dishes, >95% of the cells
expressed YFP (Figure 3.2D). This suggested that during the cardiac fibroblast isolation process
or by culturing of these SNAIL1-IRES-YFP fibroblasts on high tension tissue culture plates
SNAIL1 is expressed in them. However, when the SNAIL1-IRES-YFP mice were subject to Left
Anterior Descending Artery Occlusion, none of the mice survived beyond Day 2 post-surgery. In
these infarcted mice we could not detect any YFP expression by immunofluorescence in tissue
slices.

SNAIL1-CBR reporter mouse characterization
SNAIL1-CBR/TRE-SNAIL-Flag mice were generated by Dr. David Tran (University of
Florida). In these mice, the third exon of SNAIL1 is fused to the bioluminescent enzyme Clic
Beetle Red (Figure 3.3 A). The fusion allele was inserted in-frame in the endogenous SNAIL1
locus and driven by the endogenous Snail1 promoter. Thus the CBR bioluminescence is a direct
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readout of the endogenous levels of SNAIL1 protein. The SNAIL1-CBR reporter allele also has
a TRE-SNAIL1Flag construct, which can be used to temporally, and spatially overexpress flag
tagged SNAIL1 (TRE-Tetracycline responsive element). Thus when the SNAIL1-CBR / TRESNAIL1-Flag mouse is crossed to a reverse tetracycline transactivator (rtTA) expressing mouse
and doxycycline is administered to this mouse, SNAIL1-Flag will be overexpressed.
Alternatively, if the SNAIL1-CBR / TRE-SNAIL1-Flag mouse is crossed to the tetracycline
transactivator tTA expressing mouse, SNAIL1-Flag will be overexpressed in the cells expressing
the tTA transgene and doxycycline administration will stop the expression of SNAIL1-Flag. The
Flag tag can be used to distinguish endogenous v/s overexpressed SNAIL1.
The SNAIL1-CBR/ TRE-SNAIL1-Flag mice had normal patterns of SNAIL1
expression100 but mice homozygous for the SNAIL1-CBR/TRE-SNAIL1-Flag allele were not
obtained. (SNAIL1-CBR/TRE-SNAIL1-Flag allele is referred to as SNAIL1-CBR/+ henceforth
for brevity). Bioluminescence imaging of WT littermate or SNAIL1 CBR/+ mice showed that
only the reporter mice had bioluminescence signal (Figure 3.3 B). When the organs from these
mice were isolated, the heart had only minimal SNAIL1-CBR bioluminescence signal (Figure
3.3C). The CBR reporter is an enzyme and the output is light, single cell resolution can’t be
obtained but since the SNAIL1- reporter fusion has a half-life, similar to the half-life of SNAIL1,
the light emitted is directly correlated to SNAIL1-protein level100. These mice were further used
for infarction studies and for in-vitro experiment with isolated primary cardiac fibroblasts.
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SNAIL1-Flag overexpression in the heart
SNAIL1 has been shown to be necessary in cardiac fibroblasts for fibrosis, but whether
SNAIL1 is sufficient for fibrosis in the heart is unknown. To address this question, we crossed

the SNAIL1-CBR/TRE-SNAIL1-Flag mouse to MHC-rtTA expressing mouse. In this mouse,
the reverse tetracycline transactivator (rtTA) is expressed in cardiomyocytes under the myosin
heavy chain 6 promoter (MHC). Thus in the presence of doxycycline, rtTA will get activated in
the cardiomyocytes and turn on the TRE-SNAIL1-Flag, thereby overexpressing SNAIL1-Flag in
the cardiomyocytes specifically. The timeframe of the doxycycline (DOX) administration is
outlined in Figure 3.4B. The hearts of the control (-DOX) mice and experimental (+DOX) were
collected after 4 weeks of doxycycline treatment. Flag immunohistochemistry showed nuclear
SNAIL1 in cells, appeared to be cardiomyocytes (Figure 3.4 C). Protein lysates from 3 control
and 3 experimental mice were used to detect Flag expression. (Figure 3.4D). However, by
trichrome staining, excess collagen deposition was not observed in either control or experimental
cohorts (Figure 3.4E). It is possible that 4 weeks of SNAIL1 overexpression is not sufficient for
fibrosis or that SNAIL1 expression in cardiomyocytes does not cause fibrosis.

Col11-CreERT2 expression in the heart
After myocardial infarction, the transcript levels of Col1a1 increases in the infarcted
ventricular region and in the cardiac fibroblasts (Figure 2.3 and 2.13). To knockout SNAIL1 in
the heart, Col1a1-CreERT2 mice were obtained from JAX and crossed to SNAIL1 f/f mice (Dr.
Stephen Weiss, U.Michigan) and a Rosa-lox-stop-lox-tdTomato reporter (Figure 3.5A). Any cell
that expresses Cre recombinase in response to tamoxifen should turn on tdTomato reporter i.e.
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tdTomato reporter is a surrogate for SNAIL1 deletion. The time-frame of the Cre induction by
tamoxifen and the infarction is shown in Figure 3.5B. Early induction of Cre by weaning time is
necessary as the Col1a1 gene expression subsides in the adult mice (unless induced by injury).
When cardiac fibroblasts from the tamoxifen induced mouse hearts at 6 weeks of age were
isolated and cultured ex-vivo only 4% of the cells expressed the tdTomato reporter (Figure
3.5C). At 6 weeks of age, control Col1a1-CreERT 2; Rosa LSL tdTomato mice without tamoxifen
induction did not have tdTomato expression in any organ. In contrast, Col1a1-CreERT 2 ; Rosa
LSL tdTomato mice with tamoxifen induction showed tdTomato expression. Representative
heart, skin and pancreas sections are shown (Figure 3.5D). When the Snail1 f/f; Col11CreERT2;
Rosa LSL tdTomato mice were infarcted by LAD ligation and analyzed after 7 days, there was
an accumulation of tdTomato positive cells in the infarcted regions (Figure 3.6A). The Snail1 f/f;
Col11CreERT2; Rosa LSL tdTomato had reduced cardiac fibrosis in the ventricular regions as
determined by masons trichrome staining as compared to wild type (WT) infarcted hearts (Figure
3.6 C and D). A caveat to these observations is that the WT controls are not genetic controls (i.e.
Snail1+/+ Col11CreERT2; Rosa LSL tdTomato).

CAG-CreER and Rosa-CreERT2 (inducible global Cre recombinase) expression in the
heart
Alternative to using an inducible cardiac fibroblast specific Cre (Col1a1-CreERT2), we
sought use of a global inducible Cre to knock out SNAIL1 in the entire mouse and study the
effect of SNAIL1 deletion in the infarcted myocardium following LAD ligation surgery. Using
an inducible Cre to knock out SNAIL1 in adult is necessary, as using a ubiquitous Cre
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recombinase like Actin-Cre would cause the embryos to die in-utero, possibly due to failure of
epithelial cells to undergo EMT and migration during gastrulation. Although SNAIL1 will
potentially be deleted in the entire animal following tamoxifen exposure, we would be
determining the effect of SNAIL1 deletion in all the cells that contribute to cardiac fibrosis
(including Bone Marrow Derived progenitor cells) and not specifically (myo)fibroblasts.
Snail1f/+; CAG CreER; Rosa-LSL-mTmG mice were generated (Figure 3.7A). In this
mouse, the inducible Cre recombinase (CreER) is driven by Chicken Actin Globin (CAG)
promoter that is ubiquitously expressed. The mTmG reporter switched from membranetdTomato (i.e. red) at baseline to membrane-GFP (i.e. green) after tamoxifen treatment. To
characterize the efficiency of the CAG CreER, we treated Snail1 f/+; CAG CreER; Rosa-LSLmTmG with tamoxifen and the non-tamoxifen treated mice were used as controls. The
experimental timeline is outlined in figure 3.7 B. In the absence of induction by tamoxifen, we
observed green cells (i.e. recombined reporter) in the tissue sections of the mice. The proportion
of green cells increased after tamoxifen treatment of the mice (Figure 3.7C). Shown are
representative sections for the heart and pancreas, before and after tamoxifen induction. The
leakiness of either CAG CreER or the mTmG reporter in our hands would impede the proper
interpretation of observations and hence further experiments were not carried out using this
mouse.
We sought use of another global inducible Cre (Rosa-CreERT 2) to delete SNAIL1 in the
mice. We crossed Rosa-CreERT2 mice to Snail1f/f and Rosa LSL tdTomato mice to obtain
Snail1f/f ; Rosa-CreERT2; Rosa LSL tdTomato (Figure 3.8 A). The experimental protocol is
shown in figure 3.8 B. To characterize the efficiency of Rosa-CreERT2 activation we analyzed
organs from Rosa-CreERT2; Rosa LSL tdTomato (control) and Rosa-CreERT 2; Rosa LSL
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tdTomato fed tamoxifen chow (experimental). The control mice (without tamoxifen) did not
show any reporter activity, but the tamoxifen fed mice had high number of tdTomato positive
cells in multiple organs (Figure 3.8C-H). In the heart, there were very few cells labeled with
tdTomato (<1%). This suggested that either the Rosa locus is repressed in the heart or tamoxifen
did not circulate to the heart efficiently. Due to the inefficiency of the RosaCreERT2 to label
cardiac cells, further experiments were not carried out using this mouse. However, in a control
experiment, when mammary glands from tamoxifen fed RosaCreERT2; Rosa-LSL-tdTomato
(control) and Snail1f/f; RosaCreERT2; Rosa-LSL-tdTomato (experimental) mice were analyzed,
the control mice did not have invasion of the mammary epithelium into the mammary fat pad.
This indicated that early SNAIL1 expression is necessary for proper development of the
mammary gland.

SMA Cre characterization in the heart
Since the (myo)fibroblasts in the infarct zone express SMA, we used aSMA-Cre to
target these cells in the heart. The rationale for using a non-inducible Cre is that since aSMA is
expressed mainly in activated fibroblasts and not in epithelial cells and thus knocking out
SNAIL1 using aSMA Cre would not result in embryonic lethality due to impaired gastrulation by
epithelial cells. To test this hypothesis, we generated Snail1 f/f; aSMA Cre; Rosa LSL tdTomato
mice (Figure 3.9 A). Indeed these mice made it to adulthood and they grow, breed and develop
normally. We harvested hearts from uninfarcted aSMA Cre; Rosa LSL tdTomato (control) and
Snail1f/f; aSMA Cre; Rosa LSL tdTomato mice (experimental) mice. In hearts from both the
mice we saw very few cells being labeled with the tdTomato reporter and several of these cells
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had cardiomyocyte appearance (Figure 3.9 B). Due the low labeling of cells by aSMA-Cre in the
heart before infarction, further infarction experiments were not performed using these mice.

FSP1-Cre characterization in the heart
Since Snail1 knockout using a non-inducible Cre in the heart (i.e. aSMA –Cre) led to
viable mice, we decided to use FSP1-Cre to delete SNAIL1 in the cardiac fibroblasts in mice.
FSP1 has been shown to be expressed in the infarcted myocardium using lineage tracing
/reporter studies101. We generated Snail1f/f; FSP1-Cre; Rosa LSL tdTomato mice (Figure 3.10
A). Uninjured hearts from FSP1-Cre; Rosa LSL tdTomato (control) and Snail1 f/f; FSP1-Cre;
Rosa LSL tdTomato (experimental – Snail1 KO) were analyzed for tdTomato reporter
expression (Figure 3.10 B). We observed tdTomato expression in the heart and other organs but
the identity of these cells count not be verified immunohistochemically in tissue sections (Figure
3.10 C-F). To determine whether SNAIL1 is deleted in FSP1cre (i.e. tdTomato + cells) we
isolated cardiac fibroblasts from uninjured Snail1 f/f; FSP1-Cre; Rosa LSL tdTomato (Figure 3.10
G). About 23% of the cardiac fibroblasts were tdTomato positive and only a small fraction of
these cells (< 3%) expressed SNAIL1. We subject these mice to myocardial infarction by LAD
ligation and the experimental timeline is outlined in figure 3.10 B. The adult mice were infarcted
and hearts were collected 1 week post-surgery. The Snail1f/f; FSP1-Cre; Rosa LSL tdTomato
mice hearts had decreased collagen staining by Masson’s trichrome staining in the ventricular
infarcted region as compared to the wild type control mice. (Figure 3.11 A). The fibrosis amount
was determined by color assignment of blue (collagen) and muscle (red) (Figure 3.11 B) and
quantifying the ratio of blue/total area (Figure 3.11C). The remote zone of the WT control and
infarcted mice did not have fibrosis and the heart valve in this region (arrows) was used a
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positive control for trichrome staining (Figure 3.11D). Sections from the formalin fixed hearts
from these mice showed increased tdTomato+ cells only in the infarct zone as compared to the
remote zone (Figure 3.11E). Immunofluorescence staining of these hearts indicated that the
tdTomato positive cells did not express SNAIL1 and these cells are vimentin positive (Figure
3.12A). To determine whether the tdTomato positive cells (i.e. SNAIL1 deleted cells) were
myofibroblasts we performed immunofluorescence on 7 day infarcted Snail1 f/+; FSP1 Cre; Rosa
LSL tdTomato (control) and Snail1f/f; FSP1-Cre; Rosa LSL tdTomato (experimental) hearts with
SMA antibody. Interestingly, in both the control and experimental infarcted hearts, tdTomato
positive cells were not SMA positive indicating that SMA positive myofibroblasts in the

infarct zone are derived from a lineage, distinct from FSP1+ cells as described previously102.
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Discussion
Snail1 is a zinc finger transcription factor that is expressed at very low levels in the cells
and increase in SNAIL1 levels due to various stimuli can cause a cell fate change in the cells (i.e.
EMT) or cause diseases like fibrosis. The half-life of SNAIL1 in cells is 20 minutes and it is
degraded by the ubiquitin proteasome pathway. To further our understanding of SNAIL1
regulation, it is imperative to create a proper endogenous SNAIL1 reporter without
overexpressing it.
We compared 3 endogenous SNAIL1 reporter in this study, each with its unique characteristic
(Table 3.1). The first reporter was SNAIL1-LacZ and ES cells expressing this allele under the
endogenous SNAIL1 promoter was obtained from KOMP (international knockout mouse
consortium). One SNAIL1 allele was completely replaced by the LacZ reporter and thus the cells
expressing the reporter would indicate that SNAIL1 promoter activation. This reporter would not
be useful to determine post-transcriptional modification of SNAIL1 as the LacZ is not fused to
SNAILl. The attempt to create the Snail1-LacZ reporter mouse failed as germline transmission of
SNAIL1 could not be achieved.
The second SNAIL1 reporter is SNAIL1-IRES-YFP mouse. The third exon of SNAIL1 is
fused to an IRES-YFP reporter. In this mouse, the YFP fluorescence would indicate that SNAIL1
mRNA was transcribed, as the reporter is read by an IRES sequence off the SNAIL1 mRNA.
This reporter is not suitable to study the subcellular localization or stability of SNAIL1. When
the SNAIL1-IRES-YFP reporter mouse was subject to infarction, they all died one day after
surgery.
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The third SNAIL1 reporter mouse is SNAIL1-CBR. In this mouse, the third exon of
SNAIL1 is fused to a bioluminescent enzyme Clic Beetle Red (CBR). Since it’s a fusion protein
(SNAIL1-CBR) with the same half-life as SNAIL1 itself, the reporter is a direct readout of
SNAIL1 expression. However, the reporter lacks cellular resolution as the reporter output is
light. Homozygosity of the SNAIL1-CBR allele was never achieved in mice, however. In
addition to the bioluminescence reporter, the SNAIL1-CBR mouse has a TRE-SNAIL1-Flag
overexpression cassette that can be used to induce SNAIL1 expression in a temporal and
spatially controlled manner. In cardiomyocytes, overexpression of SNAIL1 for 4 weeks was not
sufficient to induce fibrosis. It is possible that the timeframe of 4 weeks of SNAIL1 induction
was not sufficient or that SNAIL1 expression cardiomyocytes do not contribute to fibrosis. It
would be interesting to determine whether forced overexpression of SNAIL1 in the cardiac
fibroblasts is sufficient for fibrosis. This could be achieved by crossing the Col1a2-rtTA mouse
to the SNAIL1-CBR/TRE-SNAIL1-Flag mouse and administering doxycycline.
Several cardiac fibroblast Cre recombinase mouse lines have been described but most of
them lack specificity102. In our hands we determined that the Col1a1-CreERT2 mouse might be a
viable option to delete floxed genes in the cardiac fibroblasts. The collagen promoter is active
only during early development and as such tamoxifen administration in these mice have to occur
early (during weaning or earlier) to get enough labeling of cardiac fibroblasts in the adult mice.
Such early tamoxifen treatment might interfere with normal growth and development of the mice
and deleting SNAIL1 might enhance the development defect (if any). The other inducible cre’s
i.e. Chicken Actin Globin CreER (CAG-CreER) or its reporter Rosa-LSL-mTmG was leaky in
our hands. With RosaCreERT2 we didn’t achieve efficient labeling of enough cardiac cells (but
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other organs were well labeled). These two inducible Cre lines (i.e. CAG-CreER and
RosaCreERT2) mice might be useful in temporal deletion of genes in the whole animal.
We also characterized SMA-Cre and FSP1 Cre, both reported to be expressed in the
cardiac fibroblasts. We were able to obtain SNAIL1 f/f homozygous mice with either of these Cre
lines. This finding is significant as the mice develop normally and did not die in-utero as has
been observed with genetic deletion of SNAIL1.
SMA Cre did not express widely in the uninfarcted hearts. Knocking out SNAIL1 using
FSP1 Cre, we observed a decrease in cardiac fibrosis. However, this reduction cannot be

attributed to cardiac myofibroblasts in the infarct zone as SMA+ myofibroblasts and FSP1+
cells might belong to distinct lineages. It is possible that SNAIL1 deletion in the FSP+ cells
either has a paracrine effect on the myofibroblasts ability to deposit collagen and/or causes a
reduction in recruitment of fibrocytes or bone marrow derived cells to the infarct zone, which
can explain the small reduction in fibrosis observed.
The two other Cre lines that can be tested further to target cardiac fibroblasts are Col12CreER and also periostin-Cre, both of which have been shown to be expressed in the cardiac
fibroblasts in the infarcted zone post myocardial infarction.
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Figure 3.1:
Creating Snail1-LacZ reporter mouse model:
(A) SNAIL1-LacZ targeting construct. One allele of SNAIL1 is replaced by the LacZ gene under
the endogenous Snail1 promoter. Two embryonic stem cell (ES) clones AE3, AG11 carrying the
SNAIL1-LacZ reporter were obtained
(B) ES cell differentiation assay for both ES cell clones, AG3, AG11, stained for LacZ (X-Gal).
LacZ positive cells appear blue.
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Figure 3.2:
Snail1-IRES-YFP reporter mouse model:
(A) Targeting construct of Snail1-IRES-YFP knock in allele. Mouse was a kind gift from Dr.
Xin Ye (Whitehead Institute)
(B) Immunofluorescence staining with anti-GFP antibodies on FFPE normal, uninjured heart and
pancreas sections from wild type littermate and SNAIL1-IRES-YFP mouse
(D) Live cell YFP fluorescence of cardiac fibroblasts isolated from wild type littermate and
SNAIL1-IRES-YFP mouse
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Figure 3.3:
SNAIL1-CBR reporter mouse.
(A) Targeting construct of SNAIL1-CBR mouse. The third (final) exon of SNAIL1 is fused to
the Clic Beetle Red (CBR) bioluminescence enzyme and the whole construct is knocked in the
endogenous SNAIL1 locus to generate SNAIL-CBR/+ reporter mice. The TRE-SNAIL1-Flag
construct can be used to overexpress SNAIL1 in a temporally and spatially controlled manner.
(B) SNAIL1-CBR bioluminescence signal of normal WT littermate and SNAIL1-CBR/+ mice.
(C) SNAIL1-CBR bioluminescence signal of organs isolated from normal WT littermate and
SNAIL1-CBR/+ mice.

95

96

Figure 3.4
SNAIL1 overexpression in the cardiomyocytes in-vivo
(A) Genotype of the mouse used to induce overexpression of SNAIL1 in the cardiomyocytes.
(B) Timeline of doxycycline administration
(C) Immunohistochemistry for FLAG in the control (no doxycycline) and experimental (4
week’s doxycycline)
(D) Western blot for FLAG in control (no DOX) and experimental (4 weeks DOX). Each column
represents one individual mouse (3 control, 3 experimental)
(E) Representative trichrome staining images for collagen in the control (no DOX) and
experimental (4 weeks DOX). N=5 in each group.
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Figure 3.5
Col11-Cre-ERT2 characterization in the heart
(A) Genotype of the mouse
(B) Experimental timeline
(C) Cardiac fibroblasts from control (no tamoxifen) and experimental (with tamoxifen) were
isolated and imaged for tdTomato
(D) Quantification of tdTomato positive cells (of total cells) of cells shown in (figure 3.5C)
(E) Representative images of heart, skin and lungs of control (no tamoxifen) and experimental
(with tamoxifen) at 8 weeks of age, before any infarction.
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Figure 3.6
Effect of SNAIL1 knockout on cardiac fibrosis post myocardial infarction by LAD ligation
in Snail1 f/f; Col11-Cre-ERT2 ; Rosa LSL tdTomato mice
(A) Representative images of tdTomato expressing cells in the remote zone and infarct zone of
the same heart, 7 days post LAD ligation.
(B) Representative images of Trichrome staining in WT and Snail1 KO mouse in the remote and
infarct zone, 7 days post LAD ligation
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Figure 3.7
Cre-ERT2 characterization in the heart
(A) Genotype of the mouse
(B) Experimental timeline
(C) Representative images of heart and pancreas (no tamoxifen) and experimental (with
tamoxifen) at 8 weeks of age
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Figure 3.8
RosaCreERT2 characterization in the heart
(A) Genotype of the mouse
(B) Experimental timeline
(C-H) Representative images of heart, kidney, liver, lungs, mammary glands and pancreas from
experimental at 6 weeks of age
(I) Mammary gland whole mount from a WT and Tamoxifen treated Snail1f/f; RosaCreERT2
mouse
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Figure 3.9
SMA-Cre characterization in the heart
(A) Genotype of the mouse
(B) Experimental timeline
(C-F) Representative images of heart, pancreas, liver and lungs at 8 weeks of age showing
tdTomato expression.
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Figure 3.10
FSP-Cre characterization in the heart
(A) Genotype of the mouse
(B) Experimental timeline
(C-F) Representative images of heart, pancreas, liver and lungs at 8 weeks of age showing
tdTomato expression.
(G) Snail1 and tdTomato co-staining in cardiac fibroblasts isolated from Snail1 f/f; FSP1-Cre;
Rosa-LSL-tdTomato mice.
(H) Quantification of tdTomato and Snail1 from (G)
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Figure 3.11
Effect of SNAIL1 knockout on cardiac fibrosis post myocardial infarction by LAD ligation
(A) Representative trichrome staining for collagen in the infarct zone of WT and Snail1 f/f; FSP1Cre; Rosa-LSL-tdTomato mouse hearts 7 days after infarction
(B) Color assignment for images in A. Red is muscle and Blue is collagen
(C) Quantification of fibrosis from color assigned images in B
(D) Trichrome staining in the remote zone to verify trichrome staining (structures like valves and
aorta express collagen)
(E) Representative images tdTomato+ cells in the remote zone and infarcted zone in Snail1 f/f;
FSP1-Cre; Rosa-LSL-tdTomato mice 7 days after infarction
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Figure 3.12
Characterization of FSP+ cells in the heart 7 days after LAD ligation
(A) Co-immunofluorescence with Tomato+ cells (i.e. FSP1+ cells) in the infarct region with
SNAIL1 and vimentin
(B) SMA staining in control (Snail1f/+; FSP1-Cre; Rosa-LSL-tdTomato) and Snail1 KO hearts

(Snail1f/f; FSP1-Cre; Rosa-LSL-tdTomato) in the infarct region. SMA and tdTomato do not lolocalize in either the control or SNAIL1 KO tissue sections.
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In summary, we show that SNAIL1 protein is not expressed in the normal un-infarcted
hearts. SNAIL1 levels increase during hypoxic injury to the heart i.e. myocardial infarction. The
expression of SNAIL1, as determined by SNAIL1-CBR bioluminescence, is restricted to the
ventricular infarct zone and SNAIL1 expression is not observed in the remote zone of the heart
or sham hearts. The SNAIL1-CBR signal from the heart in the whole animals is obscured by the
thymus which expresses significant SNAIL1-CBR bioluminescence signal. The difference in
SNAIL1 signal between sham and infarcted hearts became apparent when the hearts were
imaged ex-vivo. The increased SNAIL1 levels in the ventricular infarct zone is positively
correlated with fibrosis and expression of pro-fibrotic cytokines. SNAIL1 is expressed
predominantly in the myofibroblasts in the heart which are marked by aSMA and periostin and
to a smaller extent in CD45+ leukocytes.
Interestingly, only a fraction of the total myofibroblasts express SNAIL1. This could be
because SNAIL1 expression is transient and not all the myofibroblasts are expressing SNAIL1
simultaneously. Moreover, SNAIL1 is an unstable protein with a half-life of 20 minutes and thus
not all myofibroblasts don’t appear positive for SNAIL1 at the same instance. Myofibroblasts are
heterogeneous as they can be derived from multiple sources and as such, not all myofibroblasts
may express SNAIL1. Alternatively, there could be other fibrosis promoting transcription factors
that are expressed in the other (non SNAIL1) expressing myofibroblasts. One of them could be
Twist1, a basic helix-loop-helix transcription factor that has very similar functions to SNAIL1,
and infact it can bind to E-box sequences. Twist 1 has been implicated in cardiac fibrosis as
well80.
The increase in SNAIL1-CBR bioluminescence signal in the heart after myocardial
infarction can be attributed to increase in SNAIL1 protein level per individual myofibroblast and
117

collectively the increased number of myofibroblasts in the infarct zone contribute to the overall
SNAIL1-CBR bioluminescence signal. The increase in SNAIL1-CBR signal also correlates to
the magnitude of cardiac injury. SNAIL1-CBR levels were higher (10 fold over sham) in Left
Anterior Descending artery (LAD) occlusion mice as compared to ischemia reperfusion (I.R)
surgery (2 fold over sham). LAD surgery causes more injury to the heart as it is a permanent
occlusion, whereas in the ischemia reperfusion surgery, the occlusion is for 30 minutes followed
by the re-perfusion injury. The ischemia-reperfusion surgery has lesser inflammation due to
surgery, as the 30 minute ligation is done a week after putting in the suture in the heart. In
contrast, when fibrosis was induced by Angiotensin II infusion to the mouse hearts, we did not
observe a significant increase in SNAIL1 bioluminescence. This could be because Angiotensin II
causes a more systemic fibrosis in the heart over a longer period of time (2 weeks) as compared
to the more rapid induction of fibrosis (1 week) by surgical methods i.e. myocardial infarction. In
Angiotensin II infusion, the fibrosis is not localized to one region of the heart but rather is
reactive fibrosis throughout the interstitial and perivascular spaces 16.
It is an important finding that SNAIL1 is expressed in the myofibroblasts in the infarct
zone. The myofibroblasts in the infarct zone can be derived from multiple sources including
activation and proliferation of resident cardiac fibroblasts, Epithelial to Mesenchymal Transition
of epicardial cells, Endothelial to Mesenchymal Transition of endothelial cells, pericytes,
circulating fibrocytes and bone marrow derived progenitor cells 26. It has been shown that
SNAIL1 can cause cells to undergo EMT, EndMT and induce migration. Thus there is a
possibility that during cardiac fibrosis, SNAIL1 is expressed in the epicardial, endothelial or
other cells, which then can become myofibroblasts and/or migrate to the infarcted regions and
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contribute to fibrosis. To address these questions, lineage tracing of the myofibroblasts from
various sources can be performed.
Many pro-fibrotic factors are secreted in the infarcted myocardium following injury.
These various factors signal through distinct pathways, but there is always cross-talk between
them. These factors include TGFb (TGFb signaling pathway), PDGF (Jak-Stat pathway),
Angiotensin II (GPCR [Gq] signaling pathway) and hypoxia (via Hif). Interestingly, all of these
factors increased SNAIL1 bioluminescence (i.e., SNAIL1 protein level) in cultured SNAIL1CBR cardiac fibroblasts. Out of these only TGFb increased SNAIL1 mRNA levels. This
suggests that during normal conditions, SNAIL1 mRNA in cardiac fibroblasts is maintained at a
low level and the resulting SNAIL1 protein is kept at a low level via the GSK3/Axin/Catenin
complex by targeting SNAIL1 for degradation by the ubiquitin proteasome pathway.
TGF is a potent pro-fibrotic cytokine which causes expression, synthesis, secretion and
accumulation of extracellular matrix, collagen I in particular. The increase in collagen
transcription is mediated through the binding of SMAD2/3 complex following TGF
stimulation. Since TFG also increases SNAIL1 transcription, we asked whether SNAIL1 might
affect collagen gene expression directly or indirectly. We have shown that SNAIL1 deletion in
cardiac fibroblasts results in decreased Collagen I gene expression and subsequently decreased
extracellular matrix deposition in-vitro. This finding suggests that the effect of SNAIL1 on
collagen synthesis probably occurs at a post transcriptional level (REALLY???). Interestingly,
SNAIL1 deletion in cardiac fibroblasts does not have an effect on other extracellular matrix gene
mRNA levels like collagen III or fibronectin.
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The cardiac fibroblasts adopt a SMA expressing myofibroblast phenotype during
cardiac fibrosis. Expression of aSMA can occur through activation of Rho > MRTF A/B > SRF
pathway in cardiac fibroblasts. In our hands we determined that SNAIL1 deletion abrogates
expression of aSMA in cardiac fibroblasts when cultured on a high stiffness environment (tissue
culture plates). In essence, lack of SNAIL1 prevents the fate change of cardiac fibroblasts into
myofibroblasts. This observation can add to the theme of SNAIL1 as a cell fate determining
protein as SNAIL1 can induce epithelial cells to undergo a mesenchymal cell fate change and is
also implicated during differentiation of embryonic stem cells into fibroblasts. In addition it is
likely that SNAIL1 could exert its effect on collagen I transcript levels by repressing mir29,
which is a repressor of collagen I mRNA and other pro-fibrotic mRNA.
In our studies we also show that the excess collagen deposited during fibrosis can
increasing SNAIL1. Cardiac fibroblasts express the Discoidin domain receptor 2 (DDR2) and it
has been shown that activation of DDR2 receptor via its ligand fibrillar collagen, can stabilize
SNAIL1 post transcriptionally. It is possible that the collagen deposited in the fibrotic scar
following cardiac injury, activates SNAIL1 via DDR2 receptor engagement, which in turn
sustains more fibrosis secreting more collagen I, creating a feed forward loop.
We attempted to knockout SNAIL1 in the cardiac fibroblasts in-vivo using several
different Cre recombinase mouse strains. Out of these only Col1a1-CreERT2 and FSP1 seemed
promising. We observed a slight reduction in fibrosis (my trichrome staining) at 7 days post
infarction, in SNAIL1 knockout mice using FSP1 Cre (Snail1 f/f; FSP1 Cre; Rosa-LSL-tdTomato)
as compared to wild type controls. However, FSP1 does not appear to be expressed in the
aSMA+ myofibroblasts in the infarct zone. Further investigation is warranted in this study with
the use of genetically control (i.e. FSP1 Cre; Rosa-LSL-tdTomato) mice.
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Future directions
Several unanswered questions remain considering the role of SNAIL1 in cardiac fibrosis.
There are several sources of cardiac myofibroblasts that accumulate in the infarct region of the
heart. We have shown that SNAIL1 might be responsible for converting the cardiac fibroblasts
into myofibroblasts in-vitro. Preliminary in-vivo data using FSP1 and Col1a1-CreERT2 to
knockout SNAIL1 suggests a role of SNAIL1 in cardiac fibroblasts to contribute to cardiac
fibrosis. However, further investigation is warranted to determine this effect in-vivo and
periostin-Cre or Col1a2-CreERT2, which has been shown to be expressed in cardiac fibroblasts,
can be used to determine this. Additionally, whether SNAIL1 expression is necessary in other
cells types like endothelial cells, pericytes, fibrocytes or bone marrow derived progenitor cells to
traffic to the infarction site and become myofibroblasts remains to be determined. This can be
achieved by deleting SNAIL1 by using crossing Snailf/f ; Rosa LSL tdTomato mice to cell type
specific Cre mice such as Tie-2Cre (endothelial); NG2-Cre (pericytes); Twist2-Cre (BMDC) 103.
Whether SNAIL1 expression in cardiac fibroblasts is sufficient to induce cardiac fibrosis
denovo is unknown. To determine this, SNAIL1-CBR / TRE-SNAIL-Flag mouse can be crossed
to Col1a2-rtTA mouse. When administered doxycycline, this mouse should overexpress SNAIL1
in the cardiac fibroblasts. However, since the collagen promoter active in the murine hearts
during development, the doxycycline induced SNAIL1 expression has to be done during early
development stages.
Our preliminary data suggests involvement of DDR2 signaling in cardiac fibroblasts to
promote fibrosis. Involvement of DDR2 during Angiotensin II mediated cardiac fibrosis has
been determined104. Thus, during cardiac fibrosis, the excessive collagen deposition might
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activate the collagen receptor DDR2 in the cardiac (myo)fibroblasts and this might stabilize
SNAIL1. Accumulation of SNAIL1 in these cells might cause a feed forward loop to synthesize
and secrete more collagen. The effect of DDR2 signaling on cardiac fibrosis can be determined
by subjecting DDR2 null mice to myocardial infarction. Alternatively DDR2 f/f mice crossed to
cardiac fibroblast specific Cre can be used for this experiment. It is likely that lack of DDR2 may
not affect initial deposition of collagen in the infarct zone but rather have an effect during the
remodeling phase of the scar formation. These experiments need to be interpreted cautiously as
DDR2 null mice have altered heart structure and impaired cardiac fibroblast function 105.
SNAIL1 affects collagen I deposition and is responsible for conversion of cardiac
fibroblasts to myofibroblasts. However, the precise molecular mechanisms that control these
pathways still needs to be determined. It is evident that the transcriptional control of collagen 1a1
and collagen 1a2 genes in response to TGF stimulation is not equivalent. SMAD2/3/4 complex
regulates transcription of Col1a2 gene directly via binding to SMAD recognition element in its
promoter. Col1a1 gene does not have a SMAD binding site in its promoter, and SMAD2 requires
a co-factor Sp1 to bind to Col1a1 promoter and induce its transcription. We see that collagen 1a1
mRNA levels decrease in absence of SNAIL1, even with TGFb stimulation. Whether SNAIL1
affects Col1a1 gene transcription as a co-activator with SMAD2/SP1 or via repressing collagen
Ia1 translation via repression of mir29 family remains to be determined. It is likely that there
might be other mechanisms by which SNAIL1 might affect collagen gene transcription.
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Therapeutic targeting of fibrosis
Although fibrosis is a widespread disease affecting multiple organs, there are very limited
therapeutic options. Managing fibrosis in the heart following myocardial infarction is especially
challenging, as the scar formation is necessary initially to prevent cardiac rupture. Ideally the
therapy needs to allow for a better scar formation, which would prevent rupture but not
propagate beyond that and allow the scar to heal overtime, thereby restoring cardiac function.
Since SNAIL1 is involved in cardiac fibrosis, targeting SNAIL1 directly or pathways that
increase SNAIL1 or the mechanisms by which SNAIL1 regulates cardiac fibrosis would
represent attractive targets.
SNAIL1 expression in the heart increases only in the cardiac fibroblasts only in the
infarct zone. Thus after fibrosis cascade is initiated in the heart following myocardial infarction
and the formed scar has stabilized the wound, blocking SNAIL1 in the infarct area either via a
siRNA delivery (retroviral or liposomal mediated carrier) or CRISPR/Cas9 mediated SNAIL1
gene excision could probably be used to reduce fibrosis. These approaches need more research
and development to be actually viable. Even if SNAIL1 is suppressed/deleted in neighboring
cardiomyocytes or other cells, it should not have serious effects as SNAIL1 is not expressed in
these cells. Another more promising approach would be to block DDR2 signaling using DDR2
blocking antibodies or other methods. MicroRNA’s which affect collagen’s can also be a target.
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Chapter 5: Materials and methods

124

Mice and animal husbandry
All mice were housed and experiments performed according to institutional guidelines.
Production of SNAIL1-CBR/+ mice has been previously described 62. SNAIL1f/f mice were
provided by S. Weiss (U. Michigan)76. All mice were on mixed genetic backgrounds.
Experiments were carried out on 8-10 week old mice. All mice were used in compliance with the
Washington University Institutional Animal Care and Use Committee under protocol
#20150145. All mouse experiments were reviewed and approved by the Washington University
Institutional Animal Care and Use Committee under protocol #20150145. Approximately 20
SNAIL1-CBR/+ mice and 20 SNAIL1f/f mice were used for these experiments.5 mice were kept
per cage with 12 hour light / 12 hour dark cycle and standard rodent chow and water available ad
libitum. The mice were monitored everyday.

Mouse surgeries and tissue processing
Left Anterior Descending Artery (LAD) occlusion and Closed Chest Ischemia – Reperfusion
(I/R) surgeries were performed at the Mouse Cardiovascular Phenotyping Core at Washington
University, in compliance with the Washington University Institutional Animal Care and Use
Committee under protocol #20150145. For Closed-Chest I/R surgery, the mice were surgically
prepped and ventilated. The mice were taped to an ECG board (lead II) to measure S-T segment
elevations during ischemia and reperfusion. After a midline incision and small “non-rib cutting”
thoracotomy, the pericardium was gently dissected to visualize the coronary anatomy. An 8-0
polypropylene suture with a U-shaped tapered needle was passed under the LAD at a consistent
level on the heart directly underneath the LA. The needle was then cut from the suture and the
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two ends of the 8-0 suture was threaded through a 0.5mm piece of PE-10 tubing that had been
previously soaked for 24 hours in 100% ethanol. The tubing formed a loose snare around the
LAD. Each end of the suture was then threaded through the end of a size 3 Kalt suture needle
and exteriorized through each side of the chestwall. The chest was closed closed with interrupted
stitches. The ends of the exteriorized 8-0 suture was tucked under the skin and the skin closed.
The mice were removed from the respirator, kept warm and allowed to recover to full
consciousness. After a recovery period of 1 week after initial instrumentation, the animals were
reanesthetized under isoflurane (1.5% maintenance) but not mechanically ventilated and ONLY
the skin above the chest wall was reopened. The 8-0 suture ends were cleared of all debris and
carefully secured in small hemostats. Ligation of the LAD for 90 minutes was accomplished by
gently pulling the hemostats apart and anchoring them until the S-T segment elevation appeared
on the EKG. The EKG was constantly monitored throughout the occlusion period to ensure
persistent ischemia. At the end of the 90 minutes, reperfusion was accomplished by releasing the
hemostats, cutting the suture close to the chest wall, and releasing the tension. Reperfusion was
confirmed by resolution of the S-T segment elevation. The skin was closed with suture and the
animal was allowed to recover on a warmer for 1-7 days.
For Permanent LAD occlusion surgery, mice were anesthetized with Ketamine/Xylazine (100/10
mg/kg) and surgically prepped and ventilated on a heated magnetic stainless steel surgical board.
After a midline incision and small “non-rib cutting” thoracotomy, the chest wall was retracted to
better expose the left ventricle and the left main coronary artery system. The left anterior
descending branch of the left coronary artery was then ligated with an 8-0 silk suture. This
occlusion will be accomplished by passing a tapered needle modified to a U-shape, underneath
the LAD at a consistent level on the heart directly underneath the left atrium and tying this suture
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directly over the vessel. Mice were then hyperventilated at 150 beats/min until the chest was
closed by purse string suture. The surgical incision was closed in two layers with an interrupted
suture pattern. The animals were allowed to recover and kept warm on a heating pad throughout
the procedure until extubation, return to sternal position, and normal activity. The mice were
monitored twice daily for 7 days.

Hearts from the infarcted mice were harvested 7 days post infarction. Hearts were rinsed in PBS
and placed in 10% neutral buffered formalin overnight at room temperature. The hearts were cut
using a zivic heart slicer into infarcted region (distal to ligation) and remote region (proximal to
ligation). The hearts sections were either placed in 70% ethanol for paraffin embedding or
cryoprotected in 30% sucrose for embedding in Optimal Cutting Temperature (OCT) compound.
For mRNA isolation, the left ventricle was dissected under a dissecting microscope and mRNA
was extracted using a Qiagen mini RNA kit.

Cardiac fibroblast isolation and cell culture
Cardiac fibroblasts were isolated according to a modified cardiomyocyte isolation protocol.
Hearts were obtained from mice after anesthetizing with isoflurane followed by cervical
dislocation. The hearts were excised, placed in sterile PBS. In a tissue culture hood, hearts were
finely minced with sterile scissors and transferred into a 50 ml falcon tube with 9 mL of
Wittenberg Isolation Medium [NaCl (116 mM), KCl (5.4mM), MgCl2 (6.7mM), glucose
(12mM), glutamine (2mM), NaHCO3 (3.5mM), KH2PO4 (1.5mM), Na2HCO3 (1mM), HEPES
(21mM), commercial vitamin solution (1X), commercial amino acid solution (1X)] supplanted
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with trypsin (1X) and collagenase II (0.8 mg/mL). The minced tissue was placed on a rotator in a
37oC incubator for 15 minutes. The tubes were spun down for 5 minutes and the supernatant
(extract 1) was discarded. The extraction process was repeated 4 times with the remaining tissue
and the supernatants (extract 2-5) were pooled, spun down and plated in p100 tissue culture
dishes in DMEM/F12 media with 10% Fetal Bovine Serum and 1% penicillin – streptomycin.
The media was changed after 6 hours to allow cells to adhere and wash away the debris. Media
was replaced every other day until cells were confluent (~5 days). Fibroblast identity was
verified by vimentin and DDR2 expression.

Bioluminescence imaging
For live animal and ex-vivo heart imaging, the mice were injected with d-luciferin 10 minutes
before imaging, anesthetized using isoflurane and imaged with the IVIS-100 instrument.
For live cell imaging, 8x103 SNAIL1-CBR/+ primary cardiac fibroblasts (passage 2 or 3) were
plated in 96 well black well plates. After 20 hours, cells were washed with PBS, and serum free,
phenol red-free medium added. After 4 hours of serum starvation, d-luciferin was added along
with one of the following: TGF (2ng/mL), PDGF (10ng/mL), Angiotensin II (1 micromol/L),
CoCl2 (400uM). The plate was imaged every 15 minutes for 4 hours with IVIS 100 instrument at
37oC with ~5% O2 flow the imaging chamber. For collagen I stimulation, the cells were serum
starved and then plated on tissue culture plates coated with 60 uL of 1 - 4 mg/mL collagen I gel
and imaged as described before.
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Cardiac fibroblast immortalization and SNAIL1 gene deletion
Cardiac fibroblasts from hearts of SNAIL1f/f; ROSA-LSL-tdTomato mice were isolated and
immortalized by allowing the cells to undergo cellular senescence i.e. ~ 15 passages. The
emergent cell line was sorted for PDGFR positive cells and cellular phenotype verified by
vimentin expression.
To delete the SNAIL1 gene, 1x106 SNAIL1f/f; ROSA-LSL-tdTomato cardiac fibroblasts were
infected with either Adeno-LacZ (control, denoted CTL) or Adeno-Cre (experimental, denoted +
Cre) viruses at an MOI of 50. The virus was removed after 4 hours, cells washed and used 48
hours post infection. The rate of infection was >98% as determined by tdTomato expression.
SNAIL1 gene deletion was verified by qPCR and western blotting. Cells were freshly infected
for each experiment.

qPCR Analyses
500 ng of mRNA was used to synthesize cDNA using the Invitrogen Superscript II kit. qPCR
was performed using 1uL of cDNA in a 20 uL reaction using the SyBr green reagents (Applied
Biosystems) on StepOnePlus instrument (Applied Biosystems). The cT values were normalized
to GAPDH and the fold change was calculated using the 2-ddCT method.

Western blotting
Western blotting was done according to standard protocols. 50ug protein was loaded in each
lane. The following antibodies were used: SNAIL1 (1:100 Cell Signaling), Periostin (1:500, gift
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from Dr. Russell Norris, MUSC),  tubulin (1:10,000 Sigma), DDR2 (1:500, Cell Signaling)
ERK (1:1000, Cell Signaling) phospho-ERK (1:1000, Cell Signaling), AKT(1:1000, Cell
Signaling), phospho-AKT(1:1000, Cell Signaling ), STAT1 (1:1000, Cell Signaling), phosphoSTAT1 (1:1000, Cell Signaling)

Ex vivo Matrix deposition and analysis
A modified scar-in-a-jar assay was used for matrix deposition by cardiac fibroblasts 106. 1x105
control or SNAIL1 knockout cells were plated on sterile 100mm coverslips overnight. The cells
were then treated everyday with fresh media containing 50 ug/mL ascorbic acid for 7 days,
supplemented with 10 ng/uL PDGF every other day. The cells were removed by treating with
prewarmed extraction buffer for 3-5 minutes (25 mmol/L Tris-HCl, pH 7.4; 150 mmol/L sodium
chloride; 0.5% Triton X-100; and 20 mmol/L ammonium hydroxide).
For collagen I immunofluorescence (1:100, BD bioscience antibody), the matrix was fixed with
4% paraformaldehyde for 10 minutes. For Sirius red staining cells were fixed in bouins fixative
for 20 minutes and washed in tap water. Staining was then performed according to standard
protocol107. Birefringence imaging was performed on the Sirius red stained sections under
polarized light108.

Histology and immunostaining
5 um sections of paraffin or OCT embedded hearts were utilized for Masson’s Trichrome
Staining (KY034, Diagnostic BioSystems) and immunofluorescence. Immunofluorescence was
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performed according to standard protocol. The following antibodies were used: SNAIL1 (1:100,

Cell Signaling), SMA (1:300, Sigma), Periostin (1:100, Cell Signaling), CD31 (1:200, Abcam),
CD45 (1:100, BD Biosciences), actinin (1:100, Abcam). For SNAIL1 immunofluorescence,

antigen retrieval was done in Nuclear Decloaker solution (CB911M, Biocare Medical) and TSA
plus kit (Perkin Elmer) was used to amplify SNAIL1 signal.

Gel Contraction Assay
5x104 CTL or Experimental (+Cre) cardiac fibroblasts were embedded in 2mg/mL of collagen I
gel (Rat tail collagen 4mg/mL, 10%FBS and 23uL of NaOH /mL of collagen). 500uL of the
cells-collagen was plated in 24 well plate in triplicate for each condition. The gel was solidified
at 37oC for 30 minutes and the gel was released from the sidewall of the well by gently running a
10uL pipette tip. 1mL of DMEM/F12 media with 2% FBS and 1% Penicillin-Streptomycin was
added on top. The gels were imaged at baseline and every 4 hours subsequently. The percent
contraction was measured by comparing the initial image area to contracted image area by
ImageJ software (surface area function). Data representative of 3 independent experiments.

Image analysis
Sirius Red stained images and birefringence images were analyzed with a custom image
segmentation algorithm written in MatLab (The Mathworks, Inc.). Images were converted from
the standard RGB color space to the CIE L*a*b* color space, which encodes perceived lightness
and color differences well. Each pixel in the image was classified as positive (collagen I) or
negative (background) based on its distance in CIE L*a*b* space to the closest member of an
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empirically determined set of positive and negative training pixels. Positive signal was quantified
as the fraction of positive pixels out of the total number of pixels in an image.

Statistics
Student’s t test was used to determine statistical significance. p values < 0.05 was considered
statistically significant.
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Abstract
SNAIL1, a zinc finger transcription factor, is considered the master regulator of Epithelial to
Mesenchymal Transition. Induction of SNAIL1 in cancer cells induces EMT and confers
invasive and migration properties to the cancer cells. SNAIL1 has also been observed to be
expressed in the tumor stromal cells and is thought to actively remodel the extra cellular matrix
(ECM), thereby increasing the invasive potential of the cancer cells. In this study, we determined
that SNAIL1 expression in the Fibroblast Specific Protein 1 (FSP1) positive stromal cells does
not play a role in MMTV-PyMT breast cancer metastasis to the lungs. However, a heterozygous
knockout of SNAIL1 in the FSP1+ cells increases metastasis of the MMTV-PyMT breast cancer
cells to the lungs.
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Introduction
SNAIL1, a zinc finger transcription factor, highly regulated protein that is normally expressed at
very low levels in normal epithelial cells 1. Expression of SNAIL1 can cause epithelial cells to
undergo a cell fate change called Epithelial to Mesenchymal transition (EMT) which confers
invasion and migration properties to epithelial cells 2. The transient expression of SNAIL1 and
subsequent induction of EMT is critical for many developmental processes, like gastrulation,
mammary duct formation by epithelial cell invasion into the mammary fat pad etc 3. Cancer
cells, which often arise from epithelial cells, express SNAIL1 and this is thought to contribute to
the invasiveness and metastatic potential of cancer cells 3. Knockout of SNAIL1 in mammary
epithelial cells in MMTV-PyMT mouse tumor models decreases the incidence of lung
metastasis4. In some studies, SNAIL1 has been shown to be expressed in the tumor-stroma
interface, suggesting a possible role of SNAIL1 in the tumor stroma 5,6 (appendix figure 1A).
Recently, it was shown that SNAIL1 expression in the tumor stroma, and not tumor cells is
predictive of survival in human breast cancer (appendix figure 1B) 7. Whether SNAIL1
expression in the tumor stroma affects breast cancer metastasis in mouse tumor models is still
unknown. In this study, we knocked out SNAIL1 in the Fibroblast Specific Protein1 (FSP1+)
expressing cells in mice with a genetic MMTV-PyMT tumor. We did not observe any significant
difference in the growth rate of tumors and the number of lung metastasis in the control and the
SNAIL1 knockout in FSP1+ cells. Surprisingly, there was a significant increase in the lung
metastasis nodules in SNAIL1 heterozygous mice. Moreover, the mammary tumors in the
SNAIL1 heterozygous mice have a more variegated appearance and the lung metastasis are
larger in size. Since SNAIL1 is self-regulated (i.e. SNAIL1 shuts down its own transcription) 8,
there is a possibility that the amount of SNAIL1 protein in a heterozygous mouse is not high
152

enough to auto-regulate its own transcription. Alternatively, the half-life of SNAIL1 in a
heterozygous cell could be doubled as the amount of SNAIL1 required to trigger self-regulation
would take twice as long to saturate. These studies are preliminary and more investigation needs
to be conducted with increased number of mice in the study.
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Materials and Methods
Mammary gland whole mount and carmine alum staining
Mammary glands +4 from adult female virgin mice at 8 weeks of age was harvested and whole
mount carmine alum staining to visualize ducts was performed as previously described 9.

Histology and immunostaining
5 um sections of paraffin embedded mammary glands were utilized for immunofluorescence
staining. Immunofluorescence was performed according to standard protocol. The following

antibodies were used: SNAIL1 (1:100, Cell Signaling), SMA (1:300, Sigma), CD31 (1:200,

Abcam), CD45 (1:100, BD Biosciences),  (1:50, DSHB), K14 (1:200, BioLegend), Vimentin
(1:200, Abcam), tdTomato (1:200, Rockland). For SNAIL1 immunofluorescence, antigen
retrieval was done in Nuclear Decloaker solution (CB911M, Biocare Medical) and TSA plus kit
(Perkin Elmer) was used to amplify SNAIL1 signal.
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Results
SNAIL1 knockout in the mammary stromal cells does not affect mammary gland
development
To knockout SNAIL1 in the stromal cells, we crossed FSP1-Cre mice to SNAIL1 f/f mice and Cre
recombinase reporter mice to generate SNAIL1f/f; FSP1-Cre; Rosa LSL tdTomato mice,
henceforth referred as SNAIL1 KO mice (Appendix figure 2A). Any cell in these mice
expressing FSP1-Cre will delete SNAIL and turn on the tdTomato reporter. The advantage of
using the FSP1-Cre as opposed to an inducible stromal Cre (like Col1a2-CreERT2) is that
Tamoxifen is not required to be administered to induce gene deletion, as tamoxifen might affect
the mammary gland. Although the disadvantage of using FSP1-cre is that SNAIL1 deletion
cannot be achieved in a temporally restricted manner.
The SNAIL1f/f; FSP1-Cre; Rosa LSL tdTomato mice were born in expected Mendelian ratios,
bred normally and no gross defects were observed in them as compared to their wild type
(SNAIL1f/f; Rosa LSL tdTomato) littermate controls. The mammary glands from adult WT and
SNAIL1 knockout appeared normal, however, the secondary and tertiary branching appeared to
be increased in the SNAIL1 knockout mammary gland (Appendix figure 2B). In a control
experiment, SNAIL1 was deleted in the entire mammary gland (and the entire animal) in a
SNAIL1f/f; Rosa-CreERT2; Rosa LSL tdTomato mouse by administering tamoxifen at 3 weeks
of age for 2 weeks and tamoxifen wash out for additional 3 weeks. The mammary glands from
these mice showed a defect in mammary gland development and invasion in the mammary fat
pad (appendix figure 2C).
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FSP1+ is expressed in mammary gland lymph node and in mammary gland fibroblasts
To determine where FSP1-Cre is expressed in the mammary gland, the entire #4 mammary gland
from virgin adult female FSP1-cre; Rosa LSL tdTomato mice was excised and directly imaged
without fixation for tdTomato. Under low magnification, bright tdTomato expression was
expressed in the mammary lymph node. Under high magnification tdTomato expressing cells
were seen surrounding in the mammary ducts and also distributed between the mammary fat
cells. This is further verified by co-immunostaining for tdTomato and cell type specific markers
for ductal epithelium (SMA), luminal epithelium (K8), basal epithelium (K14) and fibroblast
(Vimentin) (Appendix figure 4).

SNAIL1 knockout in FSP1+ cells does not affect tumor growth rate and burden.
To determine the effect of SNAIL1 deletion in the stromal cells on mammary tumor growth and
metastasis, the SNAIL1f/f; FSP1-Cre; Rosa LSL tdTomato mice were crossed to MMTV-PyMT
mice to generate SNAIL1 KO; MMTV-PyMT mice. Two groups of control mice were used:
1. SNAIL1+/+; FSP1-Cre ; Rosa LSL tdTomato; MMTV-PyMT
2. SNAIL1f/+; FSP1-Cre ; Rosa LSL tdTomato; MMTV-PyMT
PyMT was chosen as it has high penetrance and relatively quick metastasis rate to lungs. There
was no gross difference in tumor development, measured as a function of age to reach 2cm
tumor, size of the biggest tumor and average tumor volume.
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SNAIL1 gene dosage has an effect on breast cancer lung metastasis and gross tumor
characteristics
Lungs harvested from WT SNAIL1 control and SNAIL1 KO tumor bearing mice at the end point
(2cm tumor) did not show a significant difference in the number of metastasis per lobe.
However, the SNAIL1 het tumor bearing mice, had a significantly large number of metastatic
nodules per lobe. The primary tumors from these three groups of tumor bearing mice (SNAIL1
WT, SNAIL1 Heterozygous, and SNAIL1 KO) were scored for gross appearance. The WT and
the SNAIL1 KO mice had predominantly rounded tumors whereas the SNAIL1 heterozygous
knockout mice had tumors with a variegated (invasive) morphology.
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Appendix Figure 1:
A. Immunohistochemistry staining showing expression of SNAIL1 in tumor stroma
interface. T=Tumor, S=Stroma, Brown staining = SNAIL1. Adapted from Franci et.al 10
B. Kaplan _Meier analysis showing SNAIL1 expression in stroma and not tumor is
predictive of survival. Adapted from Stanisavljevic et al 7.
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Appendix Figure 2:
A. SNAIL1 knockout mouse phenotype
B. Mammary gland whole-mount from 8 week old WT and SNAIL1 knockout virgin adult
female mice.
C. Mammary gland whole mount from an 8 week old SNAIL1 knockout mouse (Snail1 f/f;
RosaCreERT2; Rosa-LSL-tdTomato).
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Appendix Figure 3:
A. tdTomato expression in a freshly isolated mammary gland from FSP1-Cre; Rosa LSL
tdTomato mice. Each successive image is a zoomed in view.
B. Immunofluorescence detection of tdTomato using tdTomato antibody.
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Appendix Figure 4:
Immunofluorescence of tdTomato and cell type specific markers in a FSP1-Cre; Rosa LSL
tdTomato mammary gland isolated from an adult virgin female mouse.
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Appendix figure 5
A. Time taken for tumor to each end point (2cm) in control (SNAIL1 f/f; MMTV-PyMT;
Rosa-LSL-tdTomato), Snail1 KO (SNAIL1f/f; MMTV-PyMT; FSP1-Cre Rosa-LSLtdTomato) and Hets (SNAIL1f/+; MMTV-PyMT; Rosa-LSL-tdTomato).
B. Volume of the biggest tumor in the above mentioned mice at end point.
C. Average tumor burden of the three groups of mice at end point of experiment.
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Appendix figure 6:
A. Total number of lung mets, quantified from H&E stained sections of the 5 lung lobes, in
control, SNAIL1 KO and Snail1Het tumor bearing mice analyzed at end point of
experiment (2cm primary tumor). 3 slides were counted for each mouse at 200micron
depth from surface.
B. Representative H&E images of lung mets at end point.
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Appendix figure 7:
A. Representative images of bulk tumor from Control, Snail1 KO and Snail1 Het mice.
B. Quantification of gross tumor morphology into rounded and variegated phenotypes. Total
number of round/variegated tumors / total tumors was used to determine the percentage
of each type.
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Discussion and future direction
Tumor stroma comprises of a large number of cell types including cancer associated fibroblasts,
tumor associated macrophages, dendritic cells and different populations of T cells 5. There isn’t a
good marker to target all stromal cells in the tumor microenvironment. Using FSP1-Cre to
knockout SNAIL1 in cancer stromal cells, we show that SNAIL1 knockout in FSP1+ stromal
cells does not affect tumor development, growth and metastasis. FSP1 is not expressed in all
tumor stroma cells and it is possible that the FSP1+ cells do not contribute to breast cancer
metastasis.
Surprisingly, in a small cohort of mice, we noticed that deleting only one copy of SNAIL1 in the
FSP1+ cells significantly increases lung metastasis and changes the tumor characteristics and
number and size of lung metastasis nodules. SNAIL1 is a transcription factor and has early and
late target genes and also regulates its own transcription. When both copies of SNAIL1 is
present, SNAIL1 protein increases, induces transcription of early and late genes and reaches a
critical concentration in the cell to become degraded by the ubiquitin proteasome system. In a
heterozygous condition, the level of SNAIL1 reaches its critical concentration in twice the
amount of time. Thus SNAIL1 target genes could be expressed for twice the normal duration
which could be responsible for the adverse effects on tumor development and metastasis.
Alternatively, in the heterozygous condition, SNAIL1 protein level is maintained at half the
critical concentration, at a level where it cannot shut down its own transcription (self-regulation).
Although statistically significant, the observation with the SNAIL1 heterozygous mice is done
on a small cohort and more mice need to be studied to make a definitive conclusion.
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Future studies need to be designed to study the knockout of SNAIL1 in the multiple stromal cells
in the tumor microenvironment. These studies could be completed by crossing the SNAIL1 f/f

mice to stromal specific Cre mice like SMA-Cre, Periostin Cre, Cola1-CreERT2, NG2-Cre etc.
and a metastatic tumor model (like MMTV-PyMT). Proper controls, especially for the inducible
Cre mice need to be considered.
Additionally, the effect of deleting SNAIL1 in the stromal cells in the metastatic site need to be
determined. These can be done by tail-vein injections of tumor cells or implanting tumor cells in
cleared mammary fat pad of stromal specific SNAIL1 knockout in mice and analyzing the
metastasis rate and burden as compared to control (WT) mice.
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